data_2mix_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mix _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 122.563 1.173 . . . . 0.58999999999999997 113.606 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 99.7 m -96.92 153.06 18.12 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.936 . . . . 1.24 110.135 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.6 -139.99 14.94 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 109.715 -1.354 . . . . 0.44 109.715 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 4.7 t -137.62 132.9 33.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.419 0.609 . . . . 1.24 110.203 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.55 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 8.4 p90 -130.5 160.56 33.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.535 -0.757 . . . . 0.94999999999999996 110.478 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -94.18 99.33 11.61 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.684 -0.487 . . . . 0.38 109.684 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.06 88.33 3.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.881 0.372 . . . . 2.1499999999999999 110.294 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.8 -76.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.46999999999999997 114.799 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -97.58 -31.82 12.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.958 0.725 . . . . 2.2000000000000002 112.958 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 168.0 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.118 0.485 . . . . 3.1600000000000001 111.595 -174.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.98 113.21 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.082 -0.963 . . . . 1.8500000000000001 109.632 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.55 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.8 t -106.4 105.43 18.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.173 -0.677 . . . . 1.1699999999999999 109.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -98.04 139.82 33.29 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.546 -0.752 . . . . 1.1000000000000001 109.771 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -176.64 -178.8 0.93 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.289 -0.414 . . . . 1.5700000000000001 110.806 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.323 0.582 . . . . 1.97 110.821 -179.582 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 114.855 1.428 . . . . 0.58999999999999997 114.855 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 52.6 t -99.01 128.89 45.24 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.4 -0.818 . . . . 1.24 110.389 -173.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.08 -156.05 25.83 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.222 -1.551 . . . . 0.44 109.222 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 20.0 m -116.03 122.89 46.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 117.77 0.785 . . . . 1.24 109.292 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.411 ' HH ' ' CB ' ' A' ' 17' ' ' SER . 0.6 OUTLIER -122.04 158.53 28.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.076 -0.511 . . . . 0.94999999999999996 110.677 -178.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -89.27 102.33 15.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.069 0.461 . . . . 0.38 110.02 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -93.18 89.17 6.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.89 -0.596 . . . . 2.1499999999999999 110.47 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.07 -82.05 0.44 Allowed Glycine 0 CA--C 1.517 0.204 0 N-CA-C 114.882 0.713 . . . . 0.46999999999999997 114.882 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -118.19 4.58 11.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.013 0.406 . . . . 2.2000000000000002 111.832 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -154.67 149.17 26.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 3.1600000000000001 112.092 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -79.02 119.72 22.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.86 . . . . 1.8500000000000001 108.703 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.55 116.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.213 -0.662 . . . . 1.1699999999999999 109.213 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -92.55 135.48 34.03 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.377 0.608 . . . . 1.1000000000000001 110.331 178.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.411 ' CB ' ' HH ' ' A' ' 8' ' ' TYR . 40.2 m -151.36 154.37 36.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.598 -0.728 . . . . 1.5700000000000001 110.672 -175.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.471 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 77.8 mt-30 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.741 0.781 . . . . 1.97 109.637 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 115.932 1.827 . . . . 0.58999999999999997 115.932 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.5 m -97.98 151.74 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 1.24 110.966 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 118.74 -144.45 17.94 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 109.976 -1.25 . . . . 0.44 109.976 -173.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.9 m -123.37 124.07 42.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.98 0.39 . . . . 1.24 110.071 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.94 152.94 40.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.677 0.275 . . . . 0.94999999999999996 110.63 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -83.27 99.26 9.88 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.526 -0.47 . . . . 0.38 109.83 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.47 89.45 5.42 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.778 -0.646 . . . . 2.1499999999999999 110.517 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.96 -82.31 0.09 OUTLIER Glycine 0 CA--C 1.518 0.265 0 N-CA-C 115.06 0.784 . . . . 0.46999999999999997 115.06 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 p -98.59 -17.89 18.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.368 0.507 . . . . 2.2000000000000002 112.368 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -156.3 160.64 39.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.284 0.564 . . . . 3.1600000000000001 111.941 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 7' ' ' CYS . 18.9 t70 -81.04 116.27 20.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.093 -0.958 . . . . 1.8500000000000001 108.612 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -117.34 117.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.311 0.577 . . . . 1.1699999999999999 109.983 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 6.1 m -91.82 144.63 25.29 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.628 -0.714 . . . . 1.1000000000000001 109.785 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.3 t -174.16 153.86 2.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 1.5700000000000001 110.124 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.517 0.675 . . . . 1.97 110.142 178.021 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 112.799 0.666 . . . . 0.58999999999999997 112.799 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 88.5 m -101.07 139.66 36.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 1.24 110.576 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.1 -140.4 11.72 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.59 -1.004 . . . . 0.44 110.59 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 3.8 t -135.95 136.33 40.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.131 0.491 . . . . 1.24 110.079 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.526 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 11.3 p90 -136.73 161.12 36.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.509 -0.769 . . . . 0.94999999999999996 110.16 -175.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -95.0 98.38 10.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.91 0.386 . . . . 0.38 110.028 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -96.34 88.99 4.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.393 -0.367 . . . . 2.1499999999999999 110.33 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.94 -81.0 0.24 Allowed Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.706 -0.679 . . . . 0.46999999999999997 114.664 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -91.45 -38.45 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.397 0.517 . . . . 2.2000000000000002 112.397 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.77 167.73 24.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 3.1600000000000001 111.523 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.45 116.03 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 1.8500000000000001 109.489 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.526 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 42.5 t -111.5 108.9 26.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.905 -0.776 . . . . 1.1699999999999999 108.905 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 1.8 m -92.31 140.0 30.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.052 -0.522 . . . . 1.1000000000000001 110.299 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.8 p -164.24 -176.82 4.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.852 -0.613 . . . . 1.5700000000000001 110.103 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--O 1.233 0.234 0 N-CA-C 112.096 0.406 . . . . 1.97 112.096 -177.782 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 115.025 1.491 . . . . 0.58999999999999997 115.025 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.2 t -100.42 128.74 46.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.345 -1.298 . . . . 1.24 110.612 -169.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 134.08 -143.83 15.62 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.358 -1.097 . . . . 0.44 110.358 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.6 m -118.46 123.69 45.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.093 0.446 . . . . 1.24 110.037 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 157.6 31.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.308 -0.405 . . . . 0.94999999999999996 110.719 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -85.65 110.91 19.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.05 -0.722 . . . . 0.38 109.05 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -109.04 88.53 2.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.039 -0.528 . . . . 2.1499999999999999 110.056 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.46 -75.24 0.21 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.631 -0.713 . . . . 0.46999999999999997 114.468 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 47.9 t -108.16 -28.07 9.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.343 0.497 . . . . 2.2000000000000002 112.343 -171.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 12' ' ' SER . 3.1 mptt -137.04 165.39 26.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.442 0.639 . . . . 3.1600000000000001 111.346 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.48 116.13 23.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.643 -1.162 . . . . 1.8500000000000001 108.204 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.17 125.28 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 109.242 -0.651 . . . . 1.1699999999999999 109.242 -172.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 8.2 m -92.54 148.0 22.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.67 -0.695 . . . . 1.1000000000000001 110.698 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 t -170.67 143.58 2.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 1.5700000000000001 109.863 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.521 0.677 . . . . 1.97 110.815 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 115.021 1.489 . . . . 0.58999999999999997 115.021 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 84.3 m -93.75 162.13 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.042 -0.981 . . . . 1.24 109.868 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.68 -124.83 6.01 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -171.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 t -154.48 130.93 10.53 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.099 0.476 . . . . 1.24 110.295 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -132.22 158.41 41.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.423 -0.808 . . . . 0.94999999999999996 110.446 -176.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -82.68 89.44 6.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.47 -0.567 . . . . 0.38 109.47 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -85.21 89.19 7.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.959 -0.564 . . . . 2.1499999999999999 110.626 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.73 -75.23 0.73 Allowed Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.563 -0.744 . . . . 0.46999999999999997 114.797 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.1 m -107.69 -17.72 14.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.609 0.596 . . . . 2.2000000000000002 112.609 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -162.03 166.91 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 3.1600000000000001 110.506 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 11.1 p-10 -79.55 115.95 19.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.038 -0.727 . . . . 1.8500000000000001 109.038 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.86 107.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.747 -0.66 . . . . 1.1699999999999999 109.523 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.18 122.29 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.447 -0.797 . . . . 1.1000000000000001 110.132 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -163.89 164.46 23.37 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.722 0.296 . . . . 1.5700000000000001 111.025 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.487 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 mp0 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 121.432 0.634 . . . . 1.97 109.495 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 121.786 0.803 . . . . 0.58999999999999997 112.457 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 17' ' ' SER . 68.4 m -99.73 156.76 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.77 -0.65 . . . . 1.24 110.481 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 110.92 -155.72 15.95 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.1 -0.8 . . . . 0.44 111.1 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 65.6 m -118.39 123.82 46.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.16 0.505 . . . . 1.24 110.211 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.569 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 6.2 p90 -125.15 160.82 28.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.568 -0.742 . . . . 0.94999999999999996 110.289 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -97.3 112.33 24.19 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.102 -0.703 . . . . 0.38 109.102 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.39 89.74 3.17 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.341 0.591 . . . . 2.1499999999999999 110.474 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.77 -84.59 1.4 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.337 -0.847 . . . . 0.46999999999999997 113.994 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -117.19 -3.46 11.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.254 0.464 . . . . 2.2000000000000002 112.254 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -147.4 158.23 43.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 3.1600000000000001 112.402 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.81 117.7 29.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 1.8500000000000001 108.286 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.569 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 61.8 t -120.74 119.96 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.403 0.62 . . . . 1.1699999999999999 109.901 -171.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 53.9 m -91.69 122.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.316 -0.856 . . . . 1.1000000000000001 110.219 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 22.2 t -146.41 164.49 32.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.5700000000000001 110.001 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 1.97 110.867 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.627 0.973 . . . . 0.58999999999999997 113.627 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.9 t -102.12 128.47 48.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.834 -0.621 . . . . 1.24 109.503 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.82 20.2 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.559 -0.829 . . . . 0.44 111.228 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.3 m -115.37 123.74 49.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.551 -0.537 . . . . 1.24 109.551 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.751 ' HH ' ' HG ' ' A' ' 17' ' ' SER . 9.5 p90 -123.4 161.18 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.803 -0.635 . . . . 0.94999999999999996 110.799 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -98.03 114.45 26.6 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.043 0.449 . . . . 0.38 110.405 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.35 89.78 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 2.1499999999999999 110.546 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -87.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.46999999999999997 114.345 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -117.01 -9.18 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.0 0.4 . . . . 2.2000000000000002 111.725 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -142.88 159.86 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.085 0.469 . . . . 3.1600000000000001 110.965 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -89.92 125.89 35.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.555 -0.748 . . . . 1.8500000000000001 109.022 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.474 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 60.9 t -116.49 116.97 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 108.828 -0.804 . . . . 1.1699999999999999 108.828 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -92.22 130.36 37.95 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.58 -0.737 . . . . 1.1000000000000001 110.319 178.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.751 ' HG ' ' HH ' ' A' ' 8' ' ' TYR . 20.0 m -147.06 176.95 9.54 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.905 -1.043 . . . . 1.5700000000000001 109.416 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 120.994 0.425 . . . . 1.97 111.547 -177.394 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 113.048 0.758 . . . . 0.58999999999999997 113.048 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.5 m -100.09 137.92 37.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.834 -0.621 . . . . 1.24 110.389 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 125.02 -152.58 17.67 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.384 -0.687 . . . . 0.44 111.384 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 81.6 m -117.51 124.19 48.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.1 0.476 . . . . 1.24 110.01 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.434 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 13.4 p90 -124.86 160.57 28.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.859 -0.61 . . . . 0.94999999999999996 110.513 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -95.21 111.13 23.01 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.668 -0.413 . . . . 0.38 110.298 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.15 90.54 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.018 -0.537 . . . . 2.1499999999999999 110.618 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.86 -88.92 1.58 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.776 -0.647 . . . . 0.46999999999999997 114.044 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.9 m -117.24 -6.53 11.3 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.41 0.522 . . . . 2.2000000000000002 112.41 -173.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -147.87 167.32 25.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.416 0.627 . . . . 3.1600000000000001 112.242 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -84.49 124.86 31.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.866 -1.061 . . . . 1.8500000000000001 108.727 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.434 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.7 t -119.57 113.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.103 -0.703 . . . . 1.1699999999999999 109.103 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.4 m -93.07 148.33 22.1 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.676 -0.693 . . . . 1.1000000000000001 111.015 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -177.56 -178.8 0.77 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.58 -0.736 . . . . 1.5700000000000001 110.068 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 116.657 -0.247 . . . . 1.97 111.314 -176.115 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB3' ' H ' ' A' ' 5' ' ' CYS . 53.7 m . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.71 1.744 . . . . 0.58999999999999997 115.71 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 4' ' ' CYS . 12.4 p -102.04 138.34 39.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.401 -0.818 . . . . 1.24 111.605 -168.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 131.96 -143.67 15.26 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.075 -1.21 . . . . 0.44 110.075 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 85.9 m -119.21 123.89 45.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.197 0.498 . . . . 1.24 110.366 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.52 158.13 39.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.412 -0.358 . . . . 0.94999999999999996 110.617 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -86.43 99.85 11.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.582 -0.525 . . . . 0.38 109.582 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -91.85 88.48 6.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 2.1499999999999999 110.066 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.73 -75.17 0.23 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.945 0.738 . . . . 0.46999999999999997 114.945 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 t -111.1 -17.1 13.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.858 0.329 . . . . 2.2000000000000002 111.774 -172.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -148.38 160.16 43.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.239 0.543 . . . . 3.1600000000000001 112.013 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.06 114.63 21.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.176 -0.92 . . . . 1.8500000000000001 108.923 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.21 117.11 52.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.864 -0.607 . . . . 1.1699999999999999 109.932 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 5.5 m -92.89 146.71 23.42 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.704 -0.68 . . . . 1.1000000000000001 110.371 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -179.33 158.77 0.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 1.5700000000000001 109.998 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.404 0.621 . . . . 1.97 111.281 -176.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.429 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 111.806 0.299 . . . . 2.8100000000000001 111.806 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.656 ' HG3' ' CB ' ' A' ' 19' ' ' SER . 13.0 tpp180 -117.4 33.59 5.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.32 0.648 . . . . 4.6500000000000004 111.843 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.636 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 33.0 mt -55.9 93.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.544 0.688 . . . . 1.72 112.774 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.502 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 38.39 -160.83 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.371 -1.286 . . . . 0.58999999999999997 113.606 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.444 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 99.7 m -96.92 153.06 18.12 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.936 . . . . 1.24 110.135 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.6 -139.99 14.94 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 109.715 -1.354 . . . . 0.44 109.715 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 4.7 t -137.62 132.9 33.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.419 0.609 . . . . 1.24 110.203 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.636 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 8.4 p90 -130.5 160.56 33.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.535 -0.757 . . . . 0.94999999999999996 110.478 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -94.18 99.33 11.61 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.684 -0.487 . . . . 0.38 109.684 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 1' ' ' THR . 7.4 t30 -99.06 88.33 3.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.881 0.372 . . . . 2.1499999999999999 110.294 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.8 -76.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.46999999999999997 114.799 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -97.58 -31.82 12.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.958 0.725 . . . . 2.2000000000000002 112.958 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 168.0 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.118 0.485 . . . . 3.1600000000000001 111.595 -174.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.98 113.21 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.082 -0.963 . . . . 1.8500000000000001 109.632 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.55 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.8 t -106.4 105.43 18.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.173 -0.677 . . . . 1.1699999999999999 109.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -98.04 139.82 33.29 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.546 -0.752 . . . . 1.1000000000000001 109.771 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -176.64 -178.8 0.93 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.289 -0.414 . . . . 1.5700000000000001 110.806 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -111.51 85.49 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.323 0.582 . . . . 1.97 110.821 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.656 ' CB ' ' HG3' ' A' ' 2' ' ' ARG . 45.1 m -81.36 -47.51 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.298 -0.865 . . . . 2.3199999999999998 111.771 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' SG ' ' N ' ' A' ' 5' ' ' CYS . 25.3 p -106.44 32.48 4.45 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.265 -0.425 . . . . 1.1899999999999999 111.737 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.534 -0.746 . . . . 1.4199999999999999 110.572 -177.294 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.426 ' OG1' HG12 ' A' ' 3' ' ' ILE . 3.1 t . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.922 0.391 . . . . 2.8100000000000001 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.59 ' HG3' ' CB ' ' A' ' 19' ' ' SER . 4.7 tpp180 -89.65 30.44 1.03 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.883 0.873 . . . . 4.6500000000000004 111.614 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.552 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -48.43 95.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.341 0.867 . . . . 1.72 113.341 -173.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.452 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 38.29 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.413 -1.721 . . . . 0.58999999999999997 114.855 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 52.6 t -99.01 128.89 45.24 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.4 -0.818 . . . . 1.24 110.389 -173.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.08 -156.05 25.83 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.222 -1.551 . . . . 0.44 109.222 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 20.0 m -116.03 122.89 46.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 117.77 0.785 . . . . 1.24 109.292 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.552 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -122.04 158.53 28.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.076 -0.511 . . . . 0.94999999999999996 110.677 -178.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -89.27 102.33 15.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.069 0.461 . . . . 0.38 110.02 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -93.18 89.17 6.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.89 -0.596 . . . . 2.1499999999999999 110.47 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.07 -82.05 0.44 Allowed Glycine 0 CA--C 1.517 0.204 0 N-CA-C 114.882 0.713 . . . . 0.46999999999999997 114.882 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -118.19 4.58 11.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.013 0.406 . . . . 2.2000000000000002 111.832 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -154.67 149.17 26.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 3.1600000000000001 112.092 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -79.02 119.72 22.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.86 . . . . 1.8500000000000001 108.703 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.55 116.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.213 -0.662 . . . . 1.1699999999999999 109.213 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -92.55 135.48 34.03 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.377 0.608 . . . . 1.1000000000000001 110.331 178.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.411 ' CB ' ' HH ' ' A' ' 8' ' ' TYR . 40.2 m -151.36 154.37 36.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.598 -0.728 . . . . 1.5700000000000001 110.672 -175.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 77.8 mt-30 -105.51 77.96 1.32 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.741 0.781 . . . . 1.97 109.637 175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.59 ' CB ' ' HG3' ' A' ' 2' ' ' ARG . 5.0 m -78.13 -55.87 4.93 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.714 -1.13 . . . . 2.3199999999999998 110.452 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -96.09 15.52 20.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.164 -0.925 . . . . 1.1899999999999999 111.346 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 59.2 m . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.629 -0.7 . . . . 1.4199999999999999 110.014 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.426 HG21 ' OD1' ' A' ' 10' ' ' ASN . 4.2 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.203 0.525 . . . . 2.8100000000000001 110.71 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.629 ' CG ' ' HB3' ' A' ' 19' ' ' SER . 10.5 ttp180 -75.14 33.23 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.117 1.155 . . . . 4.6500000000000004 114.117 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.653 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -63.68 92.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 121.4 -0.813 . . . . 1.72 112.504 -177.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' C ' ' HB2' ' A' ' 19' ' ' SER . 32.9 m 41.85 -172.68 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 115.932 1.827 . . . . 0.58999999999999997 115.932 175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 78.5 m -97.98 151.74 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 1.24 110.966 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 118.74 -144.45 17.94 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 109.976 -1.25 . . . . 0.44 109.976 -173.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.9 m -123.37 124.07 42.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.98 0.39 . . . . 1.24 110.071 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.653 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -122.94 152.94 40.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.677 0.275 . . . . 0.94999999999999996 110.63 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -83.27 99.26 9.88 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.526 -0.47 . . . . 0.38 109.83 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.426 ' OD1' HG21 ' A' ' 1' ' ' THR . 8.0 t30 -95.47 89.45 5.42 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.778 -0.646 . . . . 2.1499999999999999 110.517 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.96 -82.31 0.09 OUTLIER Glycine 0 CA--C 1.518 0.265 0 N-CA-C 115.06 0.784 . . . . 0.46999999999999997 115.06 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 p -98.59 -17.89 18.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.368 0.507 . . . . 2.2000000000000002 112.368 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -156.3 160.64 39.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.284 0.564 . . . . 3.1600000000000001 111.941 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 7' ' ' CYS . 18.9 t70 -81.04 116.27 20.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.093 -0.958 . . . . 1.8500000000000001 108.612 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -117.34 117.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.311 0.577 . . . . 1.1699999999999999 109.983 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 6.1 m -91.82 144.63 25.29 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.628 -0.714 . . . . 1.1000000000000001 109.785 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.3 t -174.16 153.86 2.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 1.5700000000000001 110.124 -173.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -95.98 79.1 3.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.517 0.675 . . . . 1.97 110.142 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.629 ' HB3' ' CG ' ' A' ' 2' ' ' ARG . 5.9 m -82.52 -55.43 4.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.876 -1.056 . . . . 2.3199999999999998 111.741 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.412 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 55.2 m -88.01 32.77 0.74 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.092 0.472 . . . . 1.1899999999999999 111.065 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.754 -0.641 . . . . 1.4199999999999999 109.509 -179.652 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 120.652 0.263 . . . . 2.8100000000000001 111.157 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.756 ' O ' ' HB2' ' A' ' 19' ' ' SER . 1.7 ttm180 -106.6 24.91 11.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.232 0.613 . . . . 4.6500000000000004 109.84 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.74 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 54.1 mt -34.01 98.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.739 1.385 . . . . 1.72 114.739 -166.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER 40.71 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.563 -1.653 . . . . 0.58999999999999997 112.799 176.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 88.5 m -101.07 139.66 36.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 1.24 110.576 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.1 -140.4 11.72 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.59 -1.004 . . . . 0.44 110.59 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 3.8 t -135.95 136.33 40.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.131 0.491 . . . . 1.24 110.079 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.74 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 11.3 p90 -136.73 161.12 36.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.509 -0.769 . . . . 0.94999999999999996 110.16 -175.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -95.0 98.38 10.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.91 0.386 . . . . 0.38 110.028 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -96.34 88.99 4.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.393 -0.367 . . . . 2.1499999999999999 110.33 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.94 -81.0 0.24 Allowed Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.706 -0.679 . . . . 0.46999999999999997 114.664 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -91.45 -38.45 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.397 0.517 . . . . 2.2000000000000002 112.397 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.77 167.73 24.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 3.1600000000000001 111.523 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.45 116.03 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 1.8500000000000001 109.489 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.526 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 42.5 t -111.5 108.9 26.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.905 -0.776 . . . . 1.1699999999999999 108.905 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.551 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 1.8 m -92.31 140.0 30.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.052 -0.522 . . . . 1.1000000000000001 110.299 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.8 p -164.24 -176.82 4.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.852 -0.613 . . . . 1.5700000000000001 110.103 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -133.05 80.53 1.89 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.096 0.406 . . . . 1.97 112.096 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.756 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 4.1 t -71.44 -57.44 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.877 0.846 . . . . 2.3199999999999998 109.981 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.0 m -86.32 32.47 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.583 -1.19 . . . . 1.1899999999999999 112.297 -166.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.0 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.689 -0.672 . . . . 1.4199999999999999 110.251 -178.658 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.838 0.351 . . . . 2.8100000000000001 110.607 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.604 ' HG2' ' HB3' ' A' ' 19' ' ' SER . 33.3 ttt85 -76.47 34.6 0.14 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.352 1.061 . . . . 4.6500000000000004 112.106 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.579 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -55.34 96.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.821 0.82 . . . . 1.72 113.172 -175.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.56 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 45.86 -174.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.804 -1.544 . . . . 0.58999999999999997 115.025 177.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.2 t -100.42 128.74 46.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.345 -1.298 . . . . 1.24 110.612 -169.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 134.08 -143.83 15.62 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.358 -1.097 . . . . 0.44 110.358 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.6 m -118.46 123.69 45.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.093 0.446 . . . . 1.24 110.037 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.579 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -122.56 157.6 31.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.308 -0.405 . . . . 0.94999999999999996 110.719 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -85.65 110.91 19.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.05 -0.722 . . . . 0.38 109.05 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -109.04 88.53 2.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.039 -0.528 . . . . 2.1499999999999999 110.056 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.46 -75.24 0.21 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.631 -0.713 . . . . 0.46999999999999997 114.468 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 47.9 t -108.16 -28.07 9.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.343 0.497 . . . . 2.2000000000000002 112.343 -171.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 12' ' ' SER . 3.1 mptt -137.04 165.39 26.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.442 0.639 . . . . 3.1600000000000001 111.346 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.48 116.13 23.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.643 -1.162 . . . . 1.8500000000000001 108.204 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.17 125.28 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 109.242 -0.651 . . . . 1.1699999999999999 109.242 -172.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 8.2 m -92.54 148.0 22.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.67 -0.695 . . . . 1.1000000000000001 110.698 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 t -170.67 143.58 2.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 1.5700000000000001 109.863 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 27.9 mt-30 -93.41 78.98 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.521 0.677 . . . . 1.97 110.815 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.604 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 7.5 m -79.13 -60.88 2.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.131 -0.94 . . . . 2.3199999999999998 110.521 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.77 32.2 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.496 -0.775 . . . . 1.1899999999999999 110.875 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 95.4 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.616 -0.707 . . . . 1.4199999999999999 109.369 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.771 0.32 . . . . 2.8100000000000001 110.558 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.659 ' CG ' ' HB3' ' A' ' 19' ' ' SER . 15.1 ttp180 -76.53 29.78 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.688 0.795 . . . . 4.6500000000000004 112.701 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.464 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -56.41 93.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.771 0.796 . . . . 1.72 112.562 -173.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 40.51 -171.93 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.651 -1.613 . . . . 0.58999999999999997 115.021 -178.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 84.3 m -93.75 162.13 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.042 -0.981 . . . . 1.24 109.868 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.68 -124.83 6.01 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -171.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 t -154.48 130.93 10.53 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.099 0.476 . . . . 1.24 110.295 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -132.22 158.41 41.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.423 -0.808 . . . . 0.94999999999999996 110.446 -176.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -82.68 89.44 6.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.47 -0.567 . . . . 0.38 109.47 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -85.21 89.19 7.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.959 -0.564 . . . . 2.1499999999999999 110.626 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.73 -75.23 0.73 Allowed Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.563 -0.744 . . . . 0.46999999999999997 114.797 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.1 m -107.69 -17.72 14.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.609 0.596 . . . . 2.2000000000000002 112.609 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -162.03 166.91 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 3.1600000000000001 110.506 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 11.1 p-10 -79.55 115.95 19.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.038 -0.727 . . . . 1.8500000000000001 109.038 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.86 107.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.747 -0.66 . . . . 1.1699999999999999 109.523 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.18 122.29 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.447 -0.797 . . . . 1.1000000000000001 110.132 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -163.89 164.46 23.37 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.722 0.296 . . . . 1.5700000000000001 111.025 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.487 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 mp0 -85.97 78.31 9.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.432 0.634 . . . . 1.97 109.495 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.702 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 13.3 m -83.69 -38.54 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 2.3199999999999998 112.763 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 30.7 p -110.35 17.95 20.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.697 -0.627 . . . . 1.1899999999999999 111.267 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 36.4 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.778 -0.63 . . . . 1.4199999999999999 109.61 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.761 0.315 . . . . 2.8100000000000001 110.436 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.652 ' O ' ' HB2' ' A' ' 19' ' ' SER . 39.2 ttm180 -77.51 28.06 0.16 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.862 1.265 . . . . 4.6500000000000004 112.807 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.719 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 46.7 mt -34.25 97.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 114.249 1.203 . . . . 1.72 114.249 -169.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 39.14 -152.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.999 -1.455 . . . . 0.58999999999999997 112.457 177.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 17' ' ' SER . 68.4 m -99.73 156.76 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.77 -0.65 . . . . 1.24 110.481 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 110.92 -155.72 15.95 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.1 -0.8 . . . . 0.44 111.1 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 65.6 m -118.39 123.82 46.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.16 0.505 . . . . 1.24 110.211 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.719 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 6.2 p90 -125.15 160.82 28.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.568 -0.742 . . . . 0.94999999999999996 110.289 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -97.3 112.33 24.19 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.102 -0.703 . . . . 0.38 109.102 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.39 89.74 3.17 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.341 0.591 . . . . 2.1499999999999999 110.474 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.77 -84.59 1.4 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.337 -0.847 . . . . 0.46999999999999997 113.994 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -117.19 -3.46 11.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.254 0.464 . . . . 2.2000000000000002 112.254 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -147.4 158.23 43.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 3.1600000000000001 112.402 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.81 117.7 29.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 1.8500000000000001 108.286 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.569 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 61.8 t -120.74 119.96 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.403 0.62 . . . . 1.1699999999999999 109.901 -171.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 53.9 m -91.69 122.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.316 -0.856 . . . . 1.1000000000000001 110.219 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 22.2 t -146.41 164.49 32.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.5700000000000001 110.001 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -119.33 79.48 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 1.97 110.867 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 8.3 t -76.5 -57.41 3.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 2.3199999999999998 110.823 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 16.7 p -94.16 29.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.349 -0.842 . . . . 1.1899999999999999 112.652 -167.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.324 -0.846 . . . . 1.4199999999999999 110.622 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.693 0.282 . . . . 2.8100000000000001 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' SER . 20.7 ttt85 -99.25 24.96 7.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.969 0.908 . . . . 4.6500000000000004 110.184 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.728 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 21.2 mt -32.27 99.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.538 1.31 . . . . 1.72 114.538 -166.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.51 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 39.71 -155.16 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.397 -1.729 . . . . 0.58999999999999997 113.627 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.9 t -102.12 128.47 48.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.834 -0.621 . . . . 1.24 109.503 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.82 20.2 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.559 -0.829 . . . . 0.44 111.228 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.3 m -115.37 123.74 49.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.551 -0.537 . . . . 1.24 109.551 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.751 ' HH ' ' HG ' ' A' ' 17' ' ' SER . 9.5 p90 -123.4 161.18 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.803 -0.635 . . . . 0.94999999999999996 110.799 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -98.03 114.45 26.6 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.043 0.449 . . . . 0.38 110.405 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.35 89.78 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 2.1499999999999999 110.546 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -87.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.46999999999999997 114.345 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -117.01 -9.18 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.0 0.4 . . . . 2.2000000000000002 111.725 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -142.88 159.86 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.085 0.469 . . . . 3.1600000000000001 110.965 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -89.92 125.89 35.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.555 -0.748 . . . . 1.8500000000000001 109.022 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.474 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 60.9 t -116.49 116.97 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 108.828 -0.804 . . . . 1.1699999999999999 108.828 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -92.22 130.36 37.95 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.58 -0.737 . . . . 1.1000000000000001 110.319 178.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.751 ' HG ' ' HH ' ' A' ' 8' ' ' TYR . 20.0 m -147.06 176.95 9.54 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.905 -1.043 . . . . 1.5700000000000001 109.416 -176.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.528 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 99.1 mt-30 -132.63 79.83 1.87 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.994 0.425 . . . . 1.97 111.547 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.712 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 7.4 t -81.51 -59.4 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.738 0.78 . . . . 2.3199999999999998 110.069 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 m -87.84 32.35 0.74 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.694 -1.139 . . . . 1.1899999999999999 111.356 -171.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 18' ' ' GLN . 19.5 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.225 -0.893 . . . . 1.4199999999999999 110.049 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.026 0.441 . . . . 2.8100000000000001 110.981 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.826 ' O ' ' HB2' ' A' ' 19' ' ' SER . 12.7 tpp180 -112.48 22.43 14.64 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 109.212 -0.662 . . . . 4.6500000000000004 109.212 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.681 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.1 mt -33.99 98.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 114.736 1.384 . . . . 1.72 114.736 -163.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 42.61 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.784 -1.553 . . . . 0.58999999999999997 113.048 175.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.5 m -100.09 137.92 37.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.834 -0.621 . . . . 1.24 110.389 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 125.02 -152.58 17.67 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.384 -0.687 . . . . 0.44 111.384 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 81.6 m -117.51 124.19 48.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.1 0.476 . . . . 1.24 110.01 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.681 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 13.4 p90 -124.86 160.57 28.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.859 -0.61 . . . . 0.94999999999999996 110.513 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -95.21 111.13 23.01 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.668 -0.413 . . . . 0.38 110.298 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.15 90.54 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.018 -0.537 . . . . 2.1499999999999999 110.618 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.86 -88.92 1.58 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.776 -0.647 . . . . 0.46999999999999997 114.044 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.9 m -117.24 -6.53 11.3 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.41 0.522 . . . . 2.2000000000000002 112.41 -173.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -147.87 167.32 25.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.416 0.627 . . . . 3.1600000000000001 112.242 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -84.49 124.86 31.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.866 -1.061 . . . . 1.8500000000000001 108.727 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.7 t -119.57 113.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.103 -0.703 . . . . 1.1699999999999999 109.103 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.4 m -93.07 148.33 22.1 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.676 -0.693 . . . . 1.1000000000000001 111.015 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -177.56 -178.8 0.77 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.58 -0.736 . . . . 1.5700000000000001 110.068 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 25.7 mp0 -125.03 79.55 1.8 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.657 -0.247 . . . . 1.97 111.314 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.826 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 6.6 t -71.7 -52.45 17.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.706 0.765 . . . . 2.3199999999999998 109.741 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.2 m -84.51 12.8 6.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.494 -1.23 . . . . 1.1899999999999999 111.765 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 18' ' ' GLN . 8.4 p . . . . . 0 C--O 1.244 0.815 0 CA-C-N 116.207 -0.451 . . . . 1.4199999999999999 110.261 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.432 HG22 HD22 ' A' ' 10' ' ' ASN . 38.6 m . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.565 0.221 . . . . 2.8100000000000001 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.543 ' HG2' ' HB3' ' A' ' 19' ' ' SER . 4.4 ttp180 -75.76 32.27 0.11 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.375 0.88 . . . . 4.6500000000000004 113.375 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.467 ' O ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.44 92.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.727 0.775 . . . . 1.72 112.129 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.585 ' C ' ' HB2' ' A' ' 19' ' ' SER . 53.7 m 32.06 -167.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 115.71 1.744 . . . . 0.58999999999999997 115.71 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' H ' ' HB3' ' A' ' 4' ' ' CYS . 12.4 p -102.04 138.34 39.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.401 -0.818 . . . . 1.24 111.605 -168.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 131.96 -143.67 15.26 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.075 -1.21 . . . . 0.44 110.075 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 85.9 m -119.21 123.89 45.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.197 0.498 . . . . 1.24 110.366 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.467 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -128.52 158.13 39.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.412 -0.358 . . . . 0.94999999999999996 110.617 177.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -86.43 99.85 11.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.582 -0.525 . . . . 0.38 109.582 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.432 HD22 HG22 ' A' ' 1' ' ' THR . 54.2 t-20 -91.85 88.48 6.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 2.1499999999999999 110.066 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.73 -75.17 0.23 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.945 0.738 . . . . 0.46999999999999997 114.945 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 t -111.1 -17.1 13.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.858 0.329 . . . . 2.2000000000000002 111.774 -172.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -148.38 160.16 43.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.239 0.543 . . . . 3.1600000000000001 112.013 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.06 114.63 21.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.176 -0.92 . . . . 1.8500000000000001 108.923 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.21 117.11 52.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.864 -0.607 . . . . 1.1699999999999999 109.932 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 5.5 m -92.89 146.71 23.42 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.704 -0.68 . . . . 1.1000000000000001 110.371 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -179.33 158.77 0.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 1.5700000000000001 109.998 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 21' ' ' CYS . 48.0 mt-30 -97.16 79.02 2.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.404 0.621 . . . . 1.97 111.281 -176.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.585 ' HB2' ' C ' ' A' ' 4' ' ' CYS . 17.9 m -74.31 -60.92 2.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.529 -0.76 . . . . 2.3199999999999998 111.262 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -92.69 16.43 12.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.976 0.417 . . . . 1.1899999999999999 110.757 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 18' ' ' GLN . 35.0 m . . . . . 0 C--O 1.244 0.799 0 CA-C-O 118.736 -0.65 . . . . 1.4199999999999999 109.98 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 122.563 1.173 . . . . 0.58999999999999997 113.606 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 99.7 m -96.92 153.06 18.12 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.936 . . . . 1.1399999999999999 110.135 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.6 -139.99 14.94 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 109.715 -1.354 . . . . 0.44 109.715 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 4.7 t -137.62 132.9 33.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.419 0.609 . . . . 1.24 110.203 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.559 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 8.4 p90 -130.5 160.56 33.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.535 -0.757 . . . . 0.40999999999999998 110.478 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -94.18 99.33 11.61 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.684 -0.487 . . . . 0.33000000000000002 109.684 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.06 88.33 3.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.881 0.372 . . . . 1.46 110.294 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.8 -76.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.45000000000000001 114.799 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -97.58 -31.82 12.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.958 0.725 . . . . 1.75 112.958 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 168.0 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.118 0.485 . . . . 2.6600000000000001 111.595 -174.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.98 113.21 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.082 -0.963 . . . . 1.8500000000000001 109.632 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.559 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.8 t -106.4 105.43 18.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.173 -0.677 . . . . 0.45000000000000001 109.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -98.04 139.82 33.29 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.546 -0.752 . . . . 1.1000000000000001 109.771 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -176.64 -178.8 0.93 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.289 -0.414 . . . . 1.05 110.806 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.409 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 94.6 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.323 0.582 . . . . 1.5600000000000001 110.821 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 114.855 1.428 . . . . 0.58999999999999997 114.855 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 52.6 t -99.01 128.89 45.24 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.4 -0.818 . . . . 1.1399999999999999 110.389 -173.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.08 -156.05 25.83 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.222 -1.551 . . . . 0.44 109.222 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 20.0 m -116.03 122.89 46.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 117.77 0.785 . . . . 1.24 109.292 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.04 158.53 28.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.076 -0.511 . . . . 0.40999999999999998 110.677 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -89.27 102.33 15.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.069 0.461 . . . . 0.33000000000000002 110.02 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -93.18 89.17 6.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.89 -0.596 . . . . 1.46 110.47 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.07 -82.05 0.44 Allowed Glycine 0 CA--C 1.517 0.204 0 N-CA-C 114.882 0.713 . . . . 0.45000000000000001 114.882 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -118.19 4.58 11.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.013 0.406 . . . . 1.75 111.832 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -154.67 149.17 26.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 2.6600000000000001 112.092 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -79.02 119.72 22.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.86 . . . . 1.8500000000000001 108.703 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.55 116.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.213 -0.662 . . . . 0.45000000000000001 109.213 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -92.55 135.48 34.03 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.377 0.608 . . . . 1.1000000000000001 110.331 178.024 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.2 m -151.36 154.37 36.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.598 -0.728 . . . . 1.05 110.672 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.487 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 77.8 mt-30 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.741 0.781 . . . . 1.5600000000000001 109.637 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 115.932 1.827 . . . . 0.58999999999999997 115.932 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 17' ' ' SER . 78.5 m -97.98 151.74 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 1.1399999999999999 110.966 -173.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 118.74 -144.45 17.94 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 109.976 -1.25 . . . . 0.44 109.976 -173.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.9 m -123.37 124.07 42.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.98 0.39 . . . . 1.24 110.071 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.94 152.94 40.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.677 0.275 . . . . 0.40999999999999998 110.63 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -83.27 99.26 9.88 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.526 -0.47 . . . . 0.33000000000000002 109.83 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.47 89.45 5.42 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.778 -0.646 . . . . 1.46 110.517 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.96 -82.31 0.09 OUTLIER Glycine 0 CA--C 1.518 0.265 0 N-CA-C 115.06 0.784 . . . . 0.45000000000000001 115.06 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 p -98.59 -17.89 18.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.368 0.507 . . . . 1.75 112.368 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -156.3 160.64 39.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.284 0.564 . . . . 2.6600000000000001 111.941 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 7' ' ' CYS . 18.9 t70 -81.04 116.27 20.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.093 -0.958 . . . . 1.8500000000000001 108.612 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -117.34 117.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.311 0.577 . . . . 0.45000000000000001 109.983 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 6.1 m -91.82 144.63 25.29 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.628 -0.714 . . . . 1.1000000000000001 109.785 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t -174.16 153.86 2.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 1.05 110.124 -173.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.517 0.675 . . . . 1.5600000000000001 110.142 178.021 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 112.799 0.666 . . . . 0.58999999999999997 112.799 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 88.5 m -101.07 139.66 36.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 1.1399999999999999 110.576 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.1 -140.4 11.72 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.59 -1.004 . . . . 0.44 110.59 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 3.8 t -135.95 136.33 40.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.131 0.491 . . . . 1.24 110.079 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.532 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 11.3 p90 -136.73 161.12 36.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.509 -0.769 . . . . 0.40999999999999998 110.16 -175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -95.0 98.38 10.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.91 0.386 . . . . 0.33000000000000002 110.028 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -96.34 88.99 4.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.393 -0.367 . . . . 1.46 110.33 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.94 -81.0 0.24 Allowed Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.706 -0.679 . . . . 0.45000000000000001 114.664 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -91.45 -38.45 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.397 0.517 . . . . 1.75 112.397 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.77 167.73 24.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.6600000000000001 111.523 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.45 116.03 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 1.8500000000000001 109.489 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 42.5 t -111.5 108.9 26.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.905 -0.776 . . . . 0.45000000000000001 108.905 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 1.8 m -92.31 140.0 30.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.052 -0.522 . . . . 1.1000000000000001 110.299 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.8 p -164.24 -176.82 4.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.852 -0.613 . . . . 1.05 110.103 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 . . . . . 0 C--O 1.233 0.234 0 N-CA-C 112.096 0.406 . . . . 1.5600000000000001 112.096 -177.782 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 115.025 1.491 . . . . 0.58999999999999997 115.025 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.2 t -100.42 128.74 46.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.345 -1.298 . . . . 1.1399999999999999 110.612 -169.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 134.08 -143.83 15.62 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.358 -1.097 . . . . 0.44 110.358 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.6 m -118.46 123.69 45.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.093 0.446 . . . . 1.24 110.037 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 157.6 31.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.308 -0.405 . . . . 0.40999999999999998 110.719 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -85.65 110.91 19.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.05 -0.722 . . . . 0.33000000000000002 109.05 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -109.04 88.53 2.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.039 -0.528 . . . . 1.46 110.056 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.46 -75.24 0.21 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.631 -0.713 . . . . 0.45000000000000001 114.468 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.455 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 47.9 t -108.16 -28.07 9.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.343 0.497 . . . . 1.75 112.343 -171.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HD2' ' HB3' ' A' ' 12' ' ' SER . 3.1 mptt -137.04 165.39 26.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.442 0.639 . . . . 2.6600000000000001 111.346 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.48 116.13 23.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.643 -1.162 . . . . 1.8500000000000001 108.204 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.17 125.28 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 109.242 -0.651 . . . . 0.45000000000000001 109.242 -172.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 8.2 m -92.54 148.0 22.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.67 -0.695 . . . . 1.1000000000000001 110.698 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 t -170.67 143.58 2.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 1.05 109.863 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.521 0.677 . . . . 1.5600000000000001 110.815 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 115.021 1.489 . . . . 0.58999999999999997 115.021 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 84.3 m -93.75 162.13 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.042 -0.981 . . . . 1.1399999999999999 109.868 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.68 -124.83 6.01 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -171.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 t -154.48 130.93 10.53 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.099 0.476 . . . . 1.24 110.295 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -132.22 158.41 41.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.423 -0.808 . . . . 0.40999999999999998 110.446 -176.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -82.68 89.44 6.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.47 -0.567 . . . . 0.33000000000000002 109.47 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -85.21 89.19 7.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.959 -0.564 . . . . 1.46 110.626 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.73 -75.23 0.73 Allowed Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.563 -0.744 . . . . 0.45000000000000001 114.797 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.1 m -107.69 -17.72 14.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.609 0.596 . . . . 1.75 112.609 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -162.03 166.91 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 2.6600000000000001 110.506 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 11.1 p-10 -79.55 115.95 19.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.038 -0.727 . . . . 1.8500000000000001 109.038 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.86 107.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.747 -0.66 . . . . 0.45000000000000001 109.523 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.18 122.29 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.447 -0.797 . . . . 1.1000000000000001 110.132 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -163.89 164.46 23.37 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.722 0.296 . . . . 1.05 111.025 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.488 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 mp0 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 121.432 0.634 . . . . 1.5600000000000001 109.495 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 121.786 0.803 . . . . 0.58999999999999997 112.457 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' SER . 68.4 m -99.73 156.76 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.77 -0.65 . . . . 1.1399999999999999 110.481 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 110.92 -155.72 15.95 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.1 -0.8 . . . . 0.44 111.1 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 65.6 m -118.39 123.82 46.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.16 0.505 . . . . 1.24 110.211 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.579 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 6.2 p90 -125.15 160.82 28.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.568 -0.742 . . . . 0.40999999999999998 110.289 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -97.3 112.33 24.19 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.102 -0.703 . . . . 0.33000000000000002 109.102 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -114.39 89.74 3.17 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.341 0.591 . . . . 1.46 110.474 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.77 -84.59 1.4 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.337 -0.847 . . . . 0.45000000000000001 113.994 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -117.19 -3.46 11.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.254 0.464 . . . . 1.75 112.254 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -147.4 158.23 43.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 2.6600000000000001 112.402 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.81 117.7 29.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 1.8500000000000001 108.286 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 61.8 t -120.74 119.96 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.403 0.62 . . . . 0.45000000000000001 109.901 -171.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 53.9 m -91.69 122.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.316 -0.856 . . . . 1.1000000000000001 110.219 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 22.2 t -146.41 164.49 32.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.05 110.001 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 1.5600000000000001 110.867 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.627 0.973 . . . . 0.58999999999999997 113.627 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.9 t -102.12 128.47 48.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.834 -0.621 . . . . 1.1399999999999999 109.503 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.82 20.2 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.559 -0.829 . . . . 0.44 111.228 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.3 m -115.37 123.74 49.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.551 -0.537 . . . . 1.24 109.551 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 9.5 p90 -123.4 161.18 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.803 -0.635 . . . . 0.40999999999999998 110.799 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -98.03 114.45 26.6 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.043 0.449 . . . . 0.33000000000000002 110.405 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -114.35 89.78 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 1.46 110.546 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -87.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.45000000000000001 114.345 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -117.01 -9.18 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.0 0.4 . . . . 1.75 111.725 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -142.88 159.86 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.085 0.469 . . . . 2.6600000000000001 110.965 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -89.92 125.89 35.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.555 -0.748 . . . . 1.8500000000000001 109.022 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 60.9 t -116.49 116.97 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 108.828 -0.804 . . . . 0.45000000000000001 108.828 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -92.22 130.36 37.95 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.58 -0.737 . . . . 1.1000000000000001 110.319 178.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -147.06 176.95 9.54 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.905 -1.043 . . . . 1.05 109.416 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 120.994 0.425 . . . . 1.5600000000000001 111.547 -177.394 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 113.048 0.758 . . . . 0.58999999999999997 113.048 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.5 m -100.09 137.92 37.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.834 -0.621 . . . . 1.1399999999999999 110.389 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 125.02 -152.58 17.67 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.384 -0.687 . . . . 0.44 111.384 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 81.6 m -117.51 124.19 48.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.1 0.476 . . . . 1.24 110.01 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.441 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 13.4 p90 -124.86 160.57 28.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.859 -0.61 . . . . 0.40999999999999998 110.513 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -95.21 111.13 23.01 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.668 -0.413 . . . . 0.33000000000000002 110.298 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -115.15 90.54 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.018 -0.537 . . . . 1.46 110.618 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.86 -88.92 1.58 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.776 -0.647 . . . . 0.45000000000000001 114.044 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.9 m -117.24 -6.53 11.3 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.41 0.522 . . . . 1.75 112.41 -173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -147.87 167.32 25.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.416 0.627 . . . . 2.6600000000000001 112.242 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -84.49 124.86 31.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.866 -1.061 . . . . 1.8500000000000001 108.727 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.441 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.7 t -119.57 113.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.103 -0.703 . . . . 0.45000000000000001 109.103 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.4 m -93.07 148.33 22.1 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.676 -0.693 . . . . 1.1000000000000001 111.015 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -177.56 -178.8 0.77 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.58 -0.736 . . . . 1.05 110.068 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 116.657 -0.247 . . . . 1.5600000000000001 111.314 -176.115 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.71 1.744 . . . . 0.58999999999999997 115.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 p -102.04 138.34 39.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.401 -0.818 . . . . 1.1399999999999999 111.605 -168.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 131.96 -143.67 15.26 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.075 -1.21 . . . . 0.44 110.075 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 85.9 m -119.21 123.89 45.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.197 0.498 . . . . 1.24 110.366 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.52 158.13 39.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.412 -0.358 . . . . 0.40999999999999998 110.617 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -86.43 99.85 11.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.582 -0.525 . . . . 0.33000000000000002 109.582 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -91.85 88.48 6.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 1.46 110.066 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.73 -75.17 0.23 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.945 0.738 . . . . 0.45000000000000001 114.945 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 t -111.1 -17.1 13.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.858 0.329 . . . . 1.75 111.774 -172.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -148.38 160.16 43.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.239 0.543 . . . . 2.6600000000000001 112.013 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.06 114.63 21.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.176 -0.92 . . . . 1.8500000000000001 108.923 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.21 117.11 52.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.864 -0.607 . . . . 0.45000000000000001 109.932 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 5.5 m -92.89 146.71 23.42 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.704 -0.68 . . . . 1.1000000000000001 110.371 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -179.33 158.77 0.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 1.05 109.998 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.404 0.621 . . . . 1.5600000000000001 111.281 -176.972 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.447 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 111.806 0.299 . . . . 2.25 111.806 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.684 ' HG3' ' CB ' ' A' ' 19' ' ' SER . 13.0 tpp180 -117.4 33.59 5.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.32 0.648 . . . . 3.98 111.843 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.649 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 33.0 mt -55.9 93.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.544 0.688 . . . . 1.1499999999999999 112.774 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.501 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 38.39 -160.83 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.371 -1.286 . . . . 0.58999999999999997 113.606 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 99.7 m -96.92 153.06 18.12 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.936 . . . . 1.1399999999999999 110.135 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.6 -139.99 14.94 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 109.715 -1.354 . . . . 0.44 109.715 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 4.7 t -137.62 132.9 33.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.419 0.609 . . . . 1.24 110.203 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.649 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 8.4 p90 -130.5 160.56 33.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.535 -0.757 . . . . 0.40999999999999998 110.478 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -94.18 99.33 11.61 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.684 -0.487 . . . . 0.33000000000000002 109.684 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 1' ' ' THR . 7.4 t30 -99.06 88.33 3.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.881 0.372 . . . . 1.46 110.294 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.8 -76.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.45000000000000001 114.799 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -97.58 -31.82 12.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.958 0.725 . . . . 1.75 112.958 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 168.0 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.118 0.485 . . . . 2.6600000000000001 111.595 -174.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.98 113.21 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.082 -0.963 . . . . 1.8500000000000001 109.632 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.559 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.8 t -106.4 105.43 18.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.173 -0.677 . . . . 0.45000000000000001 109.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -98.04 139.82 33.29 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.546 -0.752 . . . . 1.1000000000000001 109.771 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -176.64 -178.8 0.93 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.289 -0.414 . . . . 1.05 110.806 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.409 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 94.6 mt-30 -111.51 85.49 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.323 0.582 . . . . 1.5600000000000001 110.821 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.684 ' CB ' ' HG3' ' A' ' 2' ' ' ARG . 45.1 m -81.36 -47.51 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.298 -0.865 . . . . 1.8400000000000001 111.771 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 5' ' ' CYS . 25.3 p -106.44 32.48 4.45 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.265 -0.425 . . . . 1.0900000000000001 111.737 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.534 -0.746 . . . . 1.4199999999999999 110.572 -177.294 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.438 ' OG1' HG12 ' A' ' 3' ' ' ILE . 3.1 t . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.922 0.391 . . . . 2.25 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.613 ' HG3' ' CB ' ' A' ' 19' ' ' SER . 4.7 tpp180 -89.65 30.44 1.03 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.883 0.873 . . . . 3.98 111.614 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.558 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -48.43 95.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.341 0.867 . . . . 1.1499999999999999 113.341 -173.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 38.29 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.413 -1.721 . . . . 0.58999999999999997 114.855 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 52.6 t -99.01 128.89 45.24 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.4 -0.818 . . . . 1.1399999999999999 110.389 -173.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.08 -156.05 25.83 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.222 -1.551 . . . . 0.44 109.222 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 20.0 m -116.03 122.89 46.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 117.77 0.785 . . . . 1.24 109.292 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -122.04 158.53 28.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.076 -0.511 . . . . 0.40999999999999998 110.677 -178.082 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -89.27 102.33 15.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.069 0.461 . . . . 0.33000000000000002 110.02 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -93.18 89.17 6.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.89 -0.596 . . . . 1.46 110.47 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.07 -82.05 0.44 Allowed Glycine 0 CA--C 1.517 0.204 0 N-CA-C 114.882 0.713 . . . . 0.45000000000000001 114.882 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -118.19 4.58 11.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.013 0.406 . . . . 1.75 111.832 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -154.67 149.17 26.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 2.6600000000000001 112.092 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -79.02 119.72 22.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.86 . . . . 1.8500000000000001 108.703 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.55 116.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.213 -0.662 . . . . 0.45000000000000001 109.213 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -92.55 135.48 34.03 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.377 0.608 . . . . 1.1000000000000001 110.331 178.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.2 m -151.36 154.37 36.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.598 -0.728 . . . . 1.05 110.672 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 77.8 mt-30 -105.51 77.96 1.32 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.741 0.781 . . . . 1.5600000000000001 109.637 175.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.613 ' CB ' ' HG3' ' A' ' 2' ' ' ARG . 5.0 m -78.13 -55.87 4.93 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.714 -1.13 . . . . 1.8400000000000001 110.452 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -96.09 15.52 20.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.164 -0.925 . . . . 1.0900000000000001 111.346 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 59.2 m . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.629 -0.7 . . . . 1.4199999999999999 110.014 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.455 HG22 ' OD1' ' A' ' 10' ' ' ASN . 4.2 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.203 0.525 . . . . 2.25 110.71 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.637 ' CG ' ' HB3' ' A' ' 19' ' ' SER . 10.5 ttp180 -75.14 33.23 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.117 1.155 . . . . 3.98 114.117 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.657 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -63.68 92.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 121.4 -0.813 . . . . 1.1499999999999999 112.504 -177.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' C ' ' HB2' ' A' ' 19' ' ' SER . 32.9 m 41.85 -172.68 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 115.932 1.827 . . . . 0.58999999999999997 115.932 175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 17' ' ' SER . 78.5 m -97.98 151.74 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 1.1399999999999999 110.966 -173.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 118.74 -144.45 17.94 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 109.976 -1.25 . . . . 0.44 109.976 -173.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.9 m -123.37 124.07 42.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.98 0.39 . . . . 1.24 110.071 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.657 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -122.94 152.94 40.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.677 0.275 . . . . 0.40999999999999998 110.63 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -83.27 99.26 9.88 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.526 -0.47 . . . . 0.33000000000000002 109.83 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' OD1' HG22 ' A' ' 1' ' ' THR . 8.0 t30 -95.47 89.45 5.42 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.778 -0.646 . . . . 1.46 110.517 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.96 -82.31 0.09 OUTLIER Glycine 0 CA--C 1.518 0.265 0 N-CA-C 115.06 0.784 . . . . 0.45000000000000001 115.06 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 p -98.59 -17.89 18.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.368 0.507 . . . . 1.75 112.368 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -156.3 160.64 39.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.284 0.564 . . . . 2.6600000000000001 111.941 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 7' ' ' CYS . 18.9 t70 -81.04 116.27 20.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.093 -0.958 . . . . 1.8500000000000001 108.612 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -117.34 117.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.311 0.577 . . . . 0.45000000000000001 109.983 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 6.1 m -91.82 144.63 25.29 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.628 -0.714 . . . . 1.1000000000000001 109.785 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t -174.16 153.86 2.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 1.05 110.124 -173.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -95.98 79.1 3.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.517 0.675 . . . . 1.5600000000000001 110.142 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.637 ' HB3' ' CG ' ' A' ' 2' ' ' ARG . 5.9 m -82.52 -55.43 4.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.876 -1.056 . . . . 1.8400000000000001 111.741 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.2 m -88.01 32.77 0.74 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.092 0.472 . . . . 1.0900000000000001 111.065 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.754 -0.641 . . . . 1.4199999999999999 109.509 -179.652 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 120.652 0.263 . . . . 2.25 111.157 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.769 ' O ' ' HB2' ' A' ' 19' ' ' SER . 1.7 ttm180 -106.6 24.91 11.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.232 0.613 . . . . 3.98 109.84 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.756 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 54.1 mt -34.01 98.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.739 1.385 . . . . 1.1499999999999999 114.739 -166.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER 40.71 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.563 -1.653 . . . . 0.58999999999999997 112.799 176.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 88.5 m -101.07 139.66 36.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 1.1399999999999999 110.576 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.1 -140.4 11.72 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.59 -1.004 . . . . 0.44 110.59 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 3.8 t -135.95 136.33 40.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.131 0.491 . . . . 1.24 110.079 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.756 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 11.3 p90 -136.73 161.12 36.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.509 -0.769 . . . . 0.40999999999999998 110.16 -175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -95.0 98.38 10.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.91 0.386 . . . . 0.33000000000000002 110.028 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -96.34 88.99 4.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.393 -0.367 . . . . 1.46 110.33 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.94 -81.0 0.24 Allowed Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.706 -0.679 . . . . 0.45000000000000001 114.664 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -91.45 -38.45 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.397 0.517 . . . . 1.75 112.397 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.77 167.73 24.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.6600000000000001 111.523 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.45 116.03 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 1.8500000000000001 109.489 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 42.5 t -111.5 108.9 26.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.905 -0.776 . . . . 0.45000000000000001 108.905 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 1.8 m -92.31 140.0 30.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.052 -0.522 . . . . 1.1000000000000001 110.299 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.8 p -164.24 -176.82 4.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.852 -0.613 . . . . 1.05 110.103 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -133.05 80.53 1.89 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.096 0.406 . . . . 1.5600000000000001 112.096 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.769 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 4.1 t -71.44 -57.44 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.877 0.846 . . . . 1.8400000000000001 109.981 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.0 m -86.32 32.47 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.583 -1.19 . . . . 1.0900000000000001 112.297 -166.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.0 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.689 -0.672 . . . . 1.4199999999999999 110.251 -178.658 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.838 0.351 . . . . 2.25 110.607 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.616 ' HG2' ' HB3' ' A' ' 19' ' ' SER . 33.3 ttt85 -76.47 34.6 0.14 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.352 1.061 . . . . 3.98 112.106 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.585 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -55.34 96.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.821 0.82 . . . . 1.1499999999999999 113.172 -175.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.558 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 45.86 -174.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.804 -1.544 . . . . 0.58999999999999997 115.025 177.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.2 t -100.42 128.74 46.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.345 -1.298 . . . . 1.1399999999999999 110.612 -169.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 134.08 -143.83 15.62 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.358 -1.097 . . . . 0.44 110.358 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.6 m -118.46 123.69 45.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.093 0.446 . . . . 1.24 110.037 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.585 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -122.56 157.6 31.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.308 -0.405 . . . . 0.40999999999999998 110.719 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -85.65 110.91 19.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.05 -0.722 . . . . 0.33000000000000002 109.05 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -109.04 88.53 2.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.039 -0.528 . . . . 1.46 110.056 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.46 -75.24 0.21 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.631 -0.713 . . . . 0.45000000000000001 114.468 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.455 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 47.9 t -108.16 -28.07 9.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.343 0.497 . . . . 1.75 112.343 -171.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HD2' ' HB3' ' A' ' 12' ' ' SER . 3.1 mptt -137.04 165.39 26.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.442 0.639 . . . . 2.6600000000000001 111.346 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.48 116.13 23.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.643 -1.162 . . . . 1.8500000000000001 108.204 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.17 125.28 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 109.242 -0.651 . . . . 0.45000000000000001 109.242 -172.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 8.2 m -92.54 148.0 22.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.67 -0.695 . . . . 1.1000000000000001 110.698 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 t -170.67 143.58 2.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 1.05 109.863 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.551 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 98.0 mt-30 -93.41 78.98 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.521 0.677 . . . . 1.5600000000000001 110.815 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.616 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 7.5 m -79.13 -60.88 2.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.131 -0.94 . . . . 1.8400000000000001 110.521 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.77 32.2 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.496 -0.775 . . . . 1.0900000000000001 110.875 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 95.4 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.616 -0.707 . . . . 1.4199999999999999 109.369 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.771 0.32 . . . . 2.25 110.558 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.668 ' CG ' ' HB3' ' A' ' 19' ' ' SER . 15.1 ttp180 -76.53 29.78 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.688 0.795 . . . . 3.98 112.701 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.466 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -56.41 93.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.771 0.796 . . . . 1.1499999999999999 112.562 -173.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 40.51 -171.93 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.651 -1.613 . . . . 0.58999999999999997 115.021 -178.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 84.3 m -93.75 162.13 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.042 -0.981 . . . . 1.1399999999999999 109.868 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.68 -124.83 6.01 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -171.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 t -154.48 130.93 10.53 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.099 0.476 . . . . 1.24 110.295 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -132.22 158.41 41.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.423 -0.808 . . . . 0.40999999999999998 110.446 -176.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -82.68 89.44 6.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.47 -0.567 . . . . 0.33000000000000002 109.47 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -85.21 89.19 7.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.959 -0.564 . . . . 1.46 110.626 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.73 -75.23 0.73 Allowed Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.563 -0.744 . . . . 0.45000000000000001 114.797 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.1 m -107.69 -17.72 14.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.609 0.596 . . . . 1.75 112.609 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -162.03 166.91 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 2.6600000000000001 110.506 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 11.1 p-10 -79.55 115.95 19.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.038 -0.727 . . . . 1.8500000000000001 109.038 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.86 107.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.747 -0.66 . . . . 0.45000000000000001 109.523 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.18 122.29 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.447 -0.797 . . . . 1.1000000000000001 110.132 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -163.89 164.46 23.37 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.722 0.296 . . . . 1.05 111.025 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.488 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 mp0 -85.97 78.31 9.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.432 0.634 . . . . 1.5600000000000001 109.495 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.698 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 13.3 m -83.69 -38.54 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 1.8400000000000001 112.763 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 30.7 p -110.35 17.95 20.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.697 -0.627 . . . . 1.0900000000000001 111.267 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 36.4 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.778 -0.63 . . . . 1.4199999999999999 109.61 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.761 0.315 . . . . 2.25 110.436 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.66 ' O ' ' HB2' ' A' ' 19' ' ' SER . 39.2 ttm180 -77.51 28.06 0.16 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.862 1.265 . . . . 3.98 112.807 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.735 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 46.7 mt -34.25 97.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 114.249 1.203 . . . . 1.1499999999999999 114.249 -169.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 39.14 -152.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.999 -1.455 . . . . 0.58999999999999997 112.457 177.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' SER . 68.4 m -99.73 156.76 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.77 -0.65 . . . . 1.1399999999999999 110.481 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 110.92 -155.72 15.95 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.1 -0.8 . . . . 0.44 111.1 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 65.6 m -118.39 123.82 46.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.16 0.505 . . . . 1.24 110.211 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.735 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 6.2 p90 -125.15 160.82 28.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.568 -0.742 . . . . 0.40999999999999998 110.289 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -97.3 112.33 24.19 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.102 -0.703 . . . . 0.33000000000000002 109.102 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.39 89.74 3.17 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.341 0.591 . . . . 1.46 110.474 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.77 -84.59 1.4 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.337 -0.847 . . . . 0.45000000000000001 113.994 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -117.19 -3.46 11.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.254 0.464 . . . . 1.75 112.254 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -147.4 158.23 43.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 2.6600000000000001 112.402 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.81 117.7 29.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 1.8500000000000001 108.286 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 61.8 t -120.74 119.96 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.403 0.62 . . . . 0.45000000000000001 109.901 -171.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 53.9 m -91.69 122.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.316 -0.856 . . . . 1.1000000000000001 110.219 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 22.2 t -146.41 164.49 32.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.05 110.001 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -119.33 79.48 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 1.5600000000000001 110.867 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.66 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 8.3 t -76.5 -57.41 3.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 1.8400000000000001 110.823 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 5' ' ' CYS . 16.7 p -94.16 29.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.349 -0.842 . . . . 1.0900000000000001 112.652 -167.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.324 -0.846 . . . . 1.4199999999999999 110.622 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.693 0.282 . . . . 2.25 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.722 ' O ' ' HB2' ' A' ' 19' ' ' SER . 20.7 ttt85 -99.25 24.96 7.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.969 0.908 . . . . 3.98 110.184 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.747 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 21.2 mt -32.27 99.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.538 1.31 . . . . 1.1499999999999999 114.538 -166.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 39.71 -155.16 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.397 -1.729 . . . . 0.58999999999999997 113.627 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.9 t -102.12 128.47 48.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.834 -0.621 . . . . 1.1399999999999999 109.503 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.82 20.2 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.559 -0.829 . . . . 0.44 111.228 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.3 m -115.37 123.74 49.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.551 -0.537 . . . . 1.24 109.551 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.747 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 9.5 p90 -123.4 161.18 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.803 -0.635 . . . . 0.40999999999999998 110.799 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -98.03 114.45 26.6 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.043 0.449 . . . . 0.33000000000000002 110.405 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -114.35 89.78 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 1.46 110.546 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -87.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.45000000000000001 114.345 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -117.01 -9.18 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.0 0.4 . . . . 1.75 111.725 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -142.88 159.86 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.085 0.469 . . . . 2.6600000000000001 110.965 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -89.92 125.89 35.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.555 -0.748 . . . . 1.8500000000000001 109.022 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 60.9 t -116.49 116.97 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 108.828 -0.804 . . . . 0.45000000000000001 108.828 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -92.22 130.36 37.95 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.58 -0.737 . . . . 1.1000000000000001 110.319 178.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -147.06 176.95 9.54 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.905 -1.043 . . . . 1.05 109.416 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.52 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 99.1 mt-30 -132.63 79.83 1.87 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.994 0.425 . . . . 1.5600000000000001 111.547 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.722 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 7.4 t -81.51 -59.4 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.738 0.78 . . . . 1.8400000000000001 110.069 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 m -87.84 32.35 0.74 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.694 -1.139 . . . . 1.0900000000000001 111.356 -171.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 18' ' ' GLN . 19.5 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.225 -0.893 . . . . 1.4199999999999999 110.049 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.026 0.441 . . . . 2.25 110.981 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.834 ' O ' ' HB2' ' A' ' 19' ' ' SER . 12.7 tpp180 -112.48 22.43 14.64 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 109.212 -0.662 . . . . 3.98 109.212 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.696 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.1 mt -33.99 98.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 114.736 1.384 . . . . 1.1499999999999999 114.736 -163.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 42.61 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.784 -1.553 . . . . 0.58999999999999997 113.048 175.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.5 m -100.09 137.92 37.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.834 -0.621 . . . . 1.1399999999999999 110.389 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 125.02 -152.58 17.67 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.384 -0.687 . . . . 0.44 111.384 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 81.6 m -117.51 124.19 48.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.1 0.476 . . . . 1.24 110.01 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.696 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 13.4 p90 -124.86 160.57 28.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.859 -0.61 . . . . 0.40999999999999998 110.513 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -95.21 111.13 23.01 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.668 -0.413 . . . . 0.33000000000000002 110.298 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -115.15 90.54 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.018 -0.537 . . . . 1.46 110.618 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.86 -88.92 1.58 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.776 -0.647 . . . . 0.45000000000000001 114.044 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.9 m -117.24 -6.53 11.3 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.41 0.522 . . . . 1.75 112.41 -173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -147.87 167.32 25.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.416 0.627 . . . . 2.6600000000000001 112.242 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -84.49 124.86 31.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.866 -1.061 . . . . 1.8500000000000001 108.727 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.441 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.7 t -119.57 113.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.103 -0.703 . . . . 0.45000000000000001 109.103 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.4 m -93.07 148.33 22.1 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.676 -0.693 . . . . 1.1000000000000001 111.015 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -177.56 -178.8 0.77 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.58 -0.736 . . . . 1.05 110.068 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 25.7 mp0 -125.03 79.55 1.8 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.657 -0.247 . . . . 1.5600000000000001 111.314 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.834 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 6.6 t -71.7 -52.45 17.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.706 0.765 . . . . 1.8400000000000001 109.741 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.2 m -84.51 12.8 6.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.494 -1.23 . . . . 1.0900000000000001 111.765 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 18' ' ' GLN . 8.4 p . . . . . 0 C--O 1.244 0.815 0 CA-C-N 116.207 -0.451 . . . . 1.4199999999999999 110.261 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.494 HG23 HD21 ' A' ' 10' ' ' ASN . 38.6 m . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.565 0.221 . . . . 2.25 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.585 ' HG2' ' HB3' ' A' ' 19' ' ' SER . 4.4 ttp180 -75.76 32.27 0.11 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.375 0.88 . . . . 3.98 113.375 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.47 ' O ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.44 92.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.727 0.775 . . . . 1.1499999999999999 112.129 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.589 ' C ' ' HB2' ' A' ' 19' ' ' SER . 53.7 m 32.06 -167.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 115.71 1.744 . . . . 0.58999999999999997 115.71 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 p -102.04 138.34 39.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.401 -0.818 . . . . 1.1399999999999999 111.605 -168.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 131.96 -143.67 15.26 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.075 -1.21 . . . . 0.44 110.075 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 85.9 m -119.21 123.89 45.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.197 0.498 . . . . 1.24 110.366 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.47 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -128.52 158.13 39.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.412 -0.358 . . . . 0.40999999999999998 110.617 177.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -86.43 99.85 11.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.582 -0.525 . . . . 0.33000000000000002 109.582 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.494 HD21 HG23 ' A' ' 1' ' ' THR . 54.2 t-20 -91.85 88.48 6.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 1.46 110.066 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.73 -75.17 0.23 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.945 0.738 . . . . 0.45000000000000001 114.945 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 t -111.1 -17.1 13.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.858 0.329 . . . . 1.75 111.774 -172.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -148.38 160.16 43.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.239 0.543 . . . . 2.6600000000000001 112.013 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.06 114.63 21.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.176 -0.92 . . . . 1.8500000000000001 108.923 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.21 117.11 52.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.864 -0.607 . . . . 0.45000000000000001 109.932 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 5.5 m -92.89 146.71 23.42 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.704 -0.68 . . . . 1.1000000000000001 110.371 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -179.33 158.77 0.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 1.05 109.998 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 21' ' ' CYS . 48.0 mt-30 -97.16 79.02 2.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.404 0.621 . . . . 1.5600000000000001 111.281 -176.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.589 ' HB2' ' C ' ' A' ' 4' ' ' CYS . 17.9 m -74.31 -60.92 2.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.529 -0.76 . . . . 1.8400000000000001 111.262 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -92.69 16.43 12.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.976 0.417 . . . . 1.0900000000000001 110.757 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 18' ' ' GLN . 35.0 m . . . . . 0 C--O 1.244 0.799 0 CA-C-O 118.736 -0.65 . . . . 1.4199999999999999 109.98 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 122.563 1.173 . . . . 0.59 113.606 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 99.7 m -96.92 153.06 18.12 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.936 . . . . 1.14 110.135 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.6 -139.99 14.94 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 109.715 -1.354 . . . . 0.44 109.715 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 4.7 t -137.62 132.9 33.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.419 0.609 . . . . 1.24 110.203 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.559 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 8.4 p90 -130.5 160.56 33.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.535 -0.757 . . . . 0.41 110.478 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -94.18 99.33 11.61 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.684 -0.487 . . . . 0.33 109.684 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -99.06 88.33 3.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.881 0.372 . . . . 1.46 110.294 176.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.8 -76.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.45 114.799 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -97.58 -31.82 12.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.958 0.725 . . . . 1.75 112.958 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 168.0 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.118 0.485 . . . . 2.66 111.595 -174.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.98 113.21 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.082 -0.963 . . . . 1.85 109.632 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.559 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.8 t -106.4 105.43 18.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.173 -0.677 . . . . 0.45 109.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -98.04 139.82 33.29 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.546 -0.752 . . . . 1.1 109.771 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -176.64 -178.8 0.93 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.289 -0.414 . . . . 1.05 110.806 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.409 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 94.6 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.323 0.582 . . . . 1.56 110.821 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 114.855 1.428 . . . . 0.59 114.855 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 52.6 t -99.01 128.89 45.24 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.4 -0.818 . . . . 1.14 110.389 -173.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.08 -156.05 25.83 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.222 -1.551 . . . . 0.44 109.222 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 20.0 m -116.03 122.89 46.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 117.77 0.785 . . . . 1.24 109.292 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.04 158.53 28.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.076 -0.511 . . . . 0.41 110.677 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -89.27 102.33 15.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.069 0.461 . . . . 0.33 110.02 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -93.18 89.17 6.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.89 -0.596 . . . . 1.46 110.47 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.07 -82.05 0.44 Allowed Glycine 0 CA--C 1.517 0.204 0 N-CA-C 114.882 0.713 . . . . 0.45 114.882 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -118.19 4.58 11.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.013 0.406 . . . . 1.75 111.832 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -154.67 149.17 26.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 2.66 112.092 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -79.02 119.72 22.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.86 . . . . 1.85 108.703 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.55 116.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.213 -0.662 . . . . 0.45 109.213 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -92.55 135.48 34.03 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.377 0.608 . . . . 1.1 110.331 178.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.2 m -151.36 154.37 36.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.598 -0.728 . . . . 1.05 110.672 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.487 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 77.8 mt-30 . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.741 0.781 . . . . 1.56 109.637 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 115.932 1.827 . . . . 0.59 115.932 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 17' ' ' SER . 78.5 m -97.98 151.74 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 1.14 110.966 -173.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 118.74 -144.45 17.94 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 109.976 -1.25 . . . . 0.44 109.976 -173.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.9 m -123.37 124.07 42.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.98 0.39 . . . . 1.24 110.071 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.94 152.94 40.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.677 0.275 . . . . 0.41 110.63 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -83.27 99.26 9.88 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.526 -0.47 . . . . 0.33 109.83 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -95.47 89.45 5.42 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.778 -0.646 . . . . 1.46 110.517 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.96 -82.31 0.09 OUTLIER Glycine 0 CA--C 1.518 0.265 0 N-CA-C 115.06 0.784 . . . . 0.45 115.06 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 p -98.59 -17.89 18.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.368 0.507 . . . . 1.75 112.368 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -156.3 160.64 39.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.284 0.564 . . . . 2.66 111.941 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 7' ' ' CYS . 18.9 t70 -81.04 116.27 20.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.093 -0.958 . . . . 1.85 108.612 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -117.34 117.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.311 0.577 . . . . 0.45 109.983 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 6.1 m -91.82 144.63 25.29 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.628 -0.714 . . . . 1.1 109.785 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t -174.16 153.86 2.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 1.05 110.124 -173.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 121.517 0.675 . . . . 1.56 110.142 178.021 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 112.799 0.666 . . . . 0.59 112.799 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 88.5 m -101.07 139.66 36.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 1.14 110.576 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.1 -140.4 11.72 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.59 -1.004 . . . . 0.44 110.59 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 3.8 t -135.95 136.33 40.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.131 0.491 . . . . 1.24 110.079 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.532 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 11.3 p90 -136.73 161.12 36.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.509 -0.769 . . . . 0.41 110.16 -175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -95.0 98.38 10.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.91 0.386 . . . . 0.33 110.028 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -96.34 88.99 4.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.393 -0.367 . . . . 1.46 110.33 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.94 -81.0 0.24 Allowed Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.706 -0.679 . . . . 0.45 114.664 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -91.45 -38.45 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.397 0.517 . . . . 1.75 112.397 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.77 167.73 24.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.66 111.523 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.45 116.03 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 1.85 109.489 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 42.5 t -111.5 108.9 26.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.905 -0.776 . . . . 0.45 108.905 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 1.8 m -92.31 140.0 30.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.052 -0.522 . . . . 1.1 110.299 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.8 p -164.24 -176.82 4.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.852 -0.613 . . . . 1.05 110.103 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--O 1.233 0.234 0 N-CA-C 112.096 0.406 . . . . 1.56 112.096 -177.782 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 115.025 1.491 . . . . 0.59 115.025 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.2 t -100.42 128.74 46.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.345 -1.298 . . . . 1.14 110.612 -169.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 134.08 -143.83 15.62 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.358 -1.097 . . . . 0.44 110.358 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.6 m -118.46 123.69 45.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.093 0.446 . . . . 1.24 110.037 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.56 157.6 31.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.308 -0.405 . . . . 0.41 110.719 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -85.65 110.91 19.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.05 -0.722 . . . . 0.33 109.05 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -109.04 88.53 2.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.039 -0.528 . . . . 1.46 110.056 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.46 -75.24 0.21 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.631 -0.713 . . . . 0.45 114.468 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.455 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 47.9 t -108.16 -28.07 9.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.343 0.497 . . . . 1.75 112.343 -171.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HD2' ' HB3' ' A' ' 12' ' ' SER . 3.1 mptt -137.04 165.39 26.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.442 0.639 . . . . 2.66 111.346 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.48 116.13 23.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.643 -1.162 . . . . 1.85 108.204 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.17 125.28 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 109.242 -0.651 . . . . 0.45 109.242 -172.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 8.2 m -92.54 148.0 22.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.67 -0.695 . . . . 1.1 110.698 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 t -170.67 143.58 2.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 1.05 109.863 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.521 0.677 . . . . 1.56 110.815 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 115.021 1.489 . . . . 0.59 115.021 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 84.3 m -93.75 162.13 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.042 -0.981 . . . . 1.14 109.868 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.68 -124.83 6.01 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -171.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 t -154.48 130.93 10.53 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.099 0.476 . . . . 1.24 110.295 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -132.22 158.41 41.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.423 -0.808 . . . . 0.41 110.446 -176.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -82.68 89.44 6.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.47 -0.567 . . . . 0.33 109.47 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -85.21 89.19 7.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.959 -0.564 . . . . 1.46 110.626 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.73 -75.23 0.73 Allowed Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.563 -0.744 . . . . 0.45 114.797 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.1 m -107.69 -17.72 14.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.609 0.596 . . . . 1.75 112.609 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -162.03 166.91 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 2.66 110.506 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 11.1 p-10 -79.55 115.95 19.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.038 -0.727 . . . . 1.85 109.038 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.86 107.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.747 -0.66 . . . . 0.45 109.523 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.18 122.29 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.447 -0.797 . . . . 1.1 110.132 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -163.89 164.46 23.37 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.722 0.296 . . . . 1.05 111.025 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.488 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 mp0 . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 121.432 0.634 . . . . 1.56 109.495 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 121.786 0.803 . . . . 0.59 112.457 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' SER . 68.4 m -99.73 156.76 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.77 -0.65 . . . . 1.14 110.481 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 110.92 -155.72 15.95 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.1 -0.8 . . . . 0.44 111.1 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 65.6 m -118.39 123.82 46.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.16 0.505 . . . . 1.24 110.211 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.579 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 6.2 p90 -125.15 160.82 28.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.568 -0.742 . . . . 0.41 110.289 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -97.3 112.33 24.19 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.102 -0.703 . . . . 0.33 109.102 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.39 89.74 3.17 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.341 0.591 . . . . 1.46 110.474 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.77 -84.59 1.4 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.337 -0.847 . . . . 0.45 113.994 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -117.19 -3.46 11.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.254 0.464 . . . . 1.75 112.254 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -147.4 158.23 43.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 2.66 112.402 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.81 117.7 29.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 1.85 108.286 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 61.8 t -120.74 119.96 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.403 0.62 . . . . 0.45 109.901 -171.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 53.9 m -91.69 122.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.316 -0.856 . . . . 1.1 110.219 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 22.2 t -146.41 164.49 32.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.05 110.001 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 1.56 110.867 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.627 0.973 . . . . 0.59 113.627 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.9 t -102.12 128.47 48.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.834 -0.621 . . . . 1.14 109.503 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.82 20.2 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.559 -0.829 . . . . 0.44 111.228 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.3 m -115.37 123.74 49.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.551 -0.537 . . . . 1.24 109.551 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 9.5 p90 -123.4 161.18 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.803 -0.635 . . . . 0.41 110.799 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -98.03 114.45 26.6 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.043 0.449 . . . . 0.33 110.405 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.35 89.78 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 1.46 110.546 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -87.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.45 114.345 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -117.01 -9.18 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.0 0.4 . . . . 1.75 111.725 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -142.88 159.86 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.085 0.469 . . . . 2.66 110.965 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -89.92 125.89 35.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.555 -0.748 . . . . 1.85 109.022 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.483 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 60.9 t -116.49 116.97 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 108.828 -0.804 . . . . 0.45 108.828 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -92.22 130.36 37.95 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.58 -0.737 . . . . 1.1 110.319 178.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -147.06 176.95 9.54 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.905 -1.043 . . . . 1.05 109.416 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 120.994 0.425 . . . . 1.56 111.547 -177.394 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 113.048 0.758 . . . . 0.59 113.048 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.5 m -100.09 137.92 37.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.834 -0.621 . . . . 1.14 110.389 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 125.02 -152.58 17.67 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.384 -0.687 . . . . 0.44 111.384 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 81.6 m -117.51 124.19 48.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.1 0.476 . . . . 1.24 110.01 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.441 ' CE1' ' HB ' ' A' ' 15' ' ' VAL . 13.4 p90 -124.86 160.57 28.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.859 -0.61 . . . . 0.41 110.513 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -95.21 111.13 23.01 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.668 -0.413 . . . . 0.33 110.298 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.15 90.54 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.018 -0.537 . . . . 1.46 110.618 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.86 -88.92 1.58 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.776 -0.647 . . . . 0.45 114.044 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.9 m -117.24 -6.53 11.3 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.41 0.522 . . . . 1.75 112.41 -173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -147.87 167.32 25.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.416 0.627 . . . . 2.66 112.242 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -84.49 124.86 31.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.866 -1.061 . . . . 1.85 108.727 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.441 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.7 t -119.57 113.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.103 -0.703 . . . . 0.45 109.103 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.4 m -93.07 148.33 22.1 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.676 -0.693 . . . . 1.1 111.015 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -177.56 -178.8 0.77 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.58 -0.736 . . . . 1.05 110.068 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-N 116.657 -0.247 . . . . 1.56 111.314 -176.115 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.7 m . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 115.71 1.744 . . . . 0.59 115.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 p -102.04 138.34 39.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.401 -0.818 . . . . 1.14 111.605 -168.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 131.96 -143.67 15.26 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.075 -1.21 . . . . 0.44 110.075 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 85.9 m -119.21 123.89 45.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.197 0.498 . . . . 1.24 110.366 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -128.52 158.13 39.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.412 -0.358 . . . . 0.41 110.617 177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -86.43 99.85 11.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.582 -0.525 . . . . 0.33 109.582 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -91.85 88.48 6.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 1.46 110.066 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.73 -75.17 0.23 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.945 0.738 . . . . 0.45 114.945 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 t -111.1 -17.1 13.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.858 0.329 . . . . 1.75 111.774 -172.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -148.38 160.16 43.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.239 0.543 . . . . 2.66 112.013 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.06 114.63 21.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.176 -0.92 . . . . 1.85 108.923 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.21 117.11 52.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.864 -0.607 . . . . 0.45 109.932 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 5.5 m -92.89 146.71 23.42 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.704 -0.68 . . . . 1.1 110.371 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -179.33 158.77 0.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 1.05 109.998 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 121.404 0.621 . . . . 1.56 111.281 -176.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.447 ' HA ' ' OD1' ' A' ' 10' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 111.806 0.299 . . . . 2.25 111.806 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.684 ' HG3' ' CB ' ' A' ' 19' ' ' SER . 13.0 tpp180 -117.4 33.59 5.55 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.32 0.648 . . . . 3.98 111.843 -177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.649 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 33.0 mt -55.9 93.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.544 0.688 . . . . 1.15 112.774 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.501 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 38.39 -160.83 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.371 -1.286 . . . . 0.59 113.606 177.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 99.7 m -96.92 153.06 18.12 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.936 . . . . 1.14 110.135 175.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.6 -139.99 14.94 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 109.715 -1.354 . . . . 0.44 109.715 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 4.7 t -137.62 132.9 33.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.419 0.609 . . . . 1.24 110.203 175.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.649 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 8.4 p90 -130.5 160.56 33.74 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.535 -0.757 . . . . 0.41 110.478 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -94.18 99.33 11.61 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.684 -0.487 . . . . 0.33 109.684 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 1' ' ' THR . 7.4 t30 -99.06 88.33 3.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.881 0.372 . . . . 1.46 110.294 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.8 -76.15 0.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.45 114.799 171.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -97.58 -31.82 12.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.958 0.725 . . . . 1.75 112.958 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.24 168.0 28.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.118 0.485 . . . . 2.66 111.595 -174.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.98 113.21 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.082 -0.963 . . . . 1.85 109.632 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.559 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.8 t -106.4 105.43 18.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.173 -0.677 . . . . 0.45 109.173 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER -98.04 139.82 33.29 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.546 -0.752 . . . . 1.1 109.771 176.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 p -176.64 -178.8 0.93 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.289 -0.414 . . . . 1.05 110.806 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.409 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 94.6 mt-30 -111.51 85.49 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.323 0.582 . . . . 1.56 110.821 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.684 ' CB ' ' HG3' ' A' ' 2' ' ' ARG . 45.1 m -81.36 -47.51 13.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.298 -0.865 . . . . 1.84 111.771 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 5' ' ' CYS . 25.3 p -106.44 32.48 4.45 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.265 -0.425 . . . . 1.09 111.737 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.534 -0.746 . . . . 1.42 110.572 -177.294 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.438 ' OG1' HG12 ' A' ' 3' ' ' ILE . 3.1 t . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.922 0.391 . . . . 2.25 110.662 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.613 ' HG3' ' CB ' ' A' ' 19' ' ' SER . 4.7 tpp180 -89.65 30.44 1.03 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 123.883 0.873 . . . . 3.98 111.614 -177.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.558 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -48.43 95.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 113.341 0.867 . . . . 1.15 113.341 -173.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 38.29 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 113.413 -1.721 . . . . 0.59 114.855 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 52.6 t -99.01 128.89 45.24 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.4 -0.818 . . . . 1.14 110.389 -173.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.08 -156.05 25.83 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.222 -1.551 . . . . 0.44 109.222 -173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 20.0 m -116.03 122.89 46.53 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 117.77 0.785 . . . . 1.24 109.292 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.558 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -122.04 158.53 28.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.076 -0.511 . . . . 0.41 110.677 -178.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -89.27 102.33 15.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.069 0.461 . . . . 0.33 110.02 177.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -93.18 89.17 6.33 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.89 -0.596 . . . . 1.46 110.47 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.07 -82.05 0.44 Allowed Glycine 0 CA--C 1.517 0.204 0 N-CA-C 114.882 0.713 . . . . 0.45 114.882 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 m -118.19 4.58 11.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.013 0.406 . . . . 1.75 111.832 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -154.67 149.17 26.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.141 0.496 . . . . 2.66 112.092 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -79.02 119.72 22.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.86 . . . . 1.85 108.703 172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.8 t -122.55 116.04 47.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 109.213 -0.662 . . . . 0.45 109.213 -175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -92.55 135.48 34.03 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.377 0.608 . . . . 1.1 110.331 178.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.2 m -151.36 154.37 36.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.598 -0.728 . . . . 1.05 110.672 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 77.8 mt-30 -105.51 77.96 1.32 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.741 0.781 . . . . 1.56 109.637 175.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.613 ' CB ' ' HG3' ' A' ' 2' ' ' ARG . 5.0 m -78.13 -55.87 4.93 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.714 -1.13 . . . . 1.84 110.452 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 60.0 m -96.09 15.52 20.54 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.164 -0.925 . . . . 1.09 111.346 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 59.2 m . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.629 -0.7 . . . . 1.42 110.014 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.455 HG22 ' OD1' ' A' ' 10' ' ' ASN . 4.2 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.203 0.525 . . . . 2.25 110.71 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.637 ' CG ' ' HB3' ' A' ' 19' ' ' SER . 10.5 ttp180 -75.14 33.23 0.1 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.117 1.155 . . . . 3.98 114.117 -172.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.657 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -63.68 92.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 121.4 -0.813 . . . . 1.15 112.504 -177.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' C ' ' HB2' ' A' ' 19' ' ' SER . 32.9 m 41.85 -172.68 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 115.932 1.827 . . . . 0.59 115.932 175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 17' ' ' SER . 78.5 m -97.98 151.74 19.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 1.14 110.966 -173.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 118.74 -144.45 17.94 Favored Glycine 0 N--CA 1.439 -1.126 0 N-CA-C 109.976 -1.25 . . . . 0.44 109.976 -173.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.9 m -123.37 124.07 42.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.98 0.39 . . . . 1.24 110.071 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.657 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -122.94 152.94 40.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.677 0.275 . . . . 0.41 110.63 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -83.27 99.26 9.88 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.526 -0.47 . . . . 0.33 109.83 175.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.455 ' OD1' HG22 ' A' ' 1' ' ' THR . 8.0 t30 -95.47 89.45 5.42 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.778 -0.646 . . . . 1.46 110.517 176.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.96 -82.31 0.09 OUTLIER Glycine 0 CA--C 1.518 0.265 0 N-CA-C 115.06 0.784 . . . . 0.45 115.06 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 p -98.59 -17.89 18.41 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.368 0.507 . . . . 1.75 112.368 -170.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.9 ptmm? -156.3 160.64 39.92 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.284 0.564 . . . . 2.66 111.941 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD2' ' HB3' ' A' ' 7' ' ' CYS . 18.9 t70 -81.04 116.27 20.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.093 -0.958 . . . . 1.85 108.612 174.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -117.34 117.92 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-O 121.311 0.577 . . . . 0.45 109.983 -171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 6.1 m -91.82 144.63 25.29 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.628 -0.714 . . . . 1.1 109.785 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t -174.16 153.86 2.12 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.812 -0.631 . . . . 1.05 110.124 -173.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -95.98 79.1 3.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.517 0.675 . . . . 1.56 110.142 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.637 ' HB3' ' CG ' ' A' ' 2' ' ' ARG . 5.9 m -82.52 -55.43 4.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.876 -1.056 . . . . 1.84 111.741 -175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.2 m -88.01 32.77 0.74 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.092 0.472 . . . . 1.09 111.065 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.754 -0.641 . . . . 1.42 109.509 -179.652 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 120.652 0.263 . . . . 2.25 111.157 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.769 ' O ' ' HB2' ' A' ' 19' ' ' SER . 1.7 ttm180 -106.6 24.91 11.88 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.232 0.613 . . . . 3.98 109.84 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.756 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 54.1 mt -34.01 98.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 114.739 1.385 . . . . 1.15 114.739 -166.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER 40.71 -153.67 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.563 -1.653 . . . . 0.59 112.799 176.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 88.5 m -101.07 139.66 36.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.085 0.469 . . . . 1.14 110.576 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.1 -140.4 11.72 Favored Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 110.59 -1.004 . . . . 0.44 110.59 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 3.8 t -135.95 136.33 40.32 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.131 0.491 . . . . 1.24 110.079 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.756 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 11.3 p90 -136.73 161.12 36.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.509 -0.769 . . . . 0.41 110.16 -175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -95.0 98.38 10.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.91 0.386 . . . . 0.33 110.028 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -96.34 88.99 4.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.393 -0.367 . . . . 1.46 110.33 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 68.94 -81.0 0.24 Allowed Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.706 -0.679 . . . . 0.45 114.664 172.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -91.45 -38.45 12.55 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.397 0.517 . . . . 1.75 112.397 -170.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.77 167.73 24.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.095 0.474 . . . . 2.66 111.523 -176.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.45 116.03 10.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.214 -0.903 . . . . 1.85 109.489 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.532 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 42.5 t -111.5 108.9 26.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.905 -0.776 . . . . 0.45 108.905 -177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 1.8 m -92.31 140.0 30.04 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.052 -0.522 . . . . 1.1 110.299 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 96.8 p -164.24 -176.82 4.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.852 -0.613 . . . . 1.05 110.103 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -133.05 80.53 1.89 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 112.096 0.406 . . . . 1.56 112.096 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.769 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 4.1 t -71.44 -57.44 4.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.877 0.846 . . . . 1.84 109.981 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 61.0 m -86.32 32.47 0.63 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.583 -1.19 . . . . 1.09 112.297 -166.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 67.0 m . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.689 -0.672 . . . . 1.42 110.251 -178.658 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.3 m . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 120.838 0.351 . . . . 2.25 110.607 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.616 ' HG2' ' HB3' ' A' ' 19' ' ' SER . 33.3 ttt85 -76.47 34.6 0.14 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.352 1.061 . . . . 3.98 112.106 -176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.585 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -55.34 96.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.821 0.82 . . . . 1.15 113.172 -175.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.558 ' C ' ' HB2' ' A' ' 19' ' ' SER . 0.1 OUTLIER 45.86 -174.6 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.804 -1.544 . . . . 0.59 115.025 177.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.2 t -100.42 128.74 46.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.345 -1.298 . . . . 1.14 110.612 -169.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 134.08 -143.83 15.62 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.358 -1.097 . . . . 0.44 110.358 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 61.6 m -118.46 123.69 45.81 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.093 0.446 . . . . 1.24 110.037 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.585 ' CD2' HG13 ' A' ' 3' ' ' ILE . 0.3 OUTLIER -122.56 157.6 31.73 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.308 -0.405 . . . . 0.41 110.719 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -85.65 110.91 19.61 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.05 -0.722 . . . . 0.33 109.05 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -109.04 88.53 2.75 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.039 -0.528 . . . . 1.46 110.056 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.46 -75.24 0.21 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.631 -0.713 . . . . 0.45 114.468 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.455 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 47.9 t -108.16 -28.07 9.71 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.343 0.497 . . . . 1.75 112.343 -171.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HD2' ' HB3' ' A' ' 12' ' ' SER . 3.1 mptt -137.04 165.39 26.15 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.442 0.639 . . . . 2.66 111.346 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.48 116.13 23.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.643 -1.162 . . . . 1.85 108.204 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.17 125.28 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 109.242 -0.651 . . . . 0.45 109.242 -172.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 8.2 m -92.54 148.0 22.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.67 -0.695 . . . . 1.1 110.698 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 t -170.67 143.58 2.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.587 -0.733 . . . . 1.05 109.863 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.551 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 27.9 mt-30 -93.41 78.98 4.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.521 0.677 . . . . 1.56 110.815 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.616 ' HB3' ' HG2' ' A' ' 2' ' ' ARG . 7.5 m -79.13 -60.88 2.2 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.131 -0.94 . . . . 1.84 110.521 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.3 m -86.77 32.2 0.67 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.496 -0.775 . . . . 1.09 110.875 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.551 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 95.4 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.616 -0.707 . . . . 1.42 109.369 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.771 0.32 . . . . 2.25 110.558 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.668 ' CG ' ' HB3' ' A' ' 19' ' ' SER . 15.1 ttp180 -76.53 29.78 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.688 0.795 . . . . 3.98 112.701 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.466 HG13 ' CD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -56.41 93.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.771 0.796 . . . . 1.15 112.562 -173.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.698 ' O ' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER 40.51 -171.93 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.651 -1.613 . . . . 0.59 115.021 -178.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 18' ' ' GLN . 84.3 m -93.75 162.13 14.05 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.042 -0.981 . . . . 1.14 109.868 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.68 -124.83 6.01 Favored Glycine 0 N--CA 1.439 -1.118 0 N-CA-C 109.678 -1.369 . . . . 0.44 109.678 -171.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 t -154.48 130.93 10.53 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.099 0.476 . . . . 1.24 110.295 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 14' ' ' ASP . 0.4 OUTLIER -132.22 158.41 41.84 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.423 -0.808 . . . . 0.41 110.446 -176.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -82.68 89.44 6.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.47 -0.567 . . . . 0.33 109.47 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -85.21 89.19 7.58 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.959 -0.564 . . . . 1.46 110.626 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.73 -75.23 0.73 Allowed Glycine 0 C--O 1.228 -0.223 0 CA-C-N 115.563 -0.744 . . . . 0.45 114.797 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.1 m -107.69 -17.72 14.01 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.609 0.596 . . . . 1.75 112.609 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -162.03 166.91 25.28 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.743 -0.383 . . . . 2.66 110.506 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 8' ' ' TYR . 11.1 p-10 -79.55 115.95 19.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.038 -0.727 . . . . 1.85 109.038 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.86 107.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.747 -0.66 . . . . 0.45 109.523 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.9 m -91.18 122.29 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.447 -0.797 . . . . 1.1 110.132 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.6 p -163.89 164.46 23.37 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.722 0.296 . . . . 1.05 111.025 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.488 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 mp0 -85.97 78.31 9.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.432 0.634 . . . . 1.56 109.495 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.698 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 13.3 m -83.69 -38.54 21.34 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.963 -1.017 . . . . 1.84 112.763 -172.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 30.7 p -110.35 17.95 20.34 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.697 -0.627 . . . . 1.09 111.267 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 18' ' ' GLN . 36.4 m . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.778 -0.63 . . . . 1.42 109.61 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 120.761 0.315 . . . . 2.25 110.436 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.66 ' O ' ' HB2' ' A' ' 19' ' ' SER . 39.2 ttm180 -77.51 28.06 0.16 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.862 1.265 . . . . 3.98 112.807 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.735 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 46.7 mt -34.25 97.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 N-CA-C 114.249 1.203 . . . . 1.15 114.249 -169.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 39.14 -152.09 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 113.999 -1.455 . . . . 0.59 112.457 177.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 17' ' ' SER . 68.4 m -99.73 156.76 16.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.77 -0.65 . . . . 1.14 110.481 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 110.92 -155.72 15.95 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.1 -0.8 . . . . 0.44 111.1 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 65.6 m -118.39 123.82 46.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.16 0.505 . . . . 1.24 110.211 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.735 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 6.2 p90 -125.15 160.82 28.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.568 -0.742 . . . . 0.41 110.289 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -97.3 112.33 24.19 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.102 -0.703 . . . . 0.33 109.102 175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.39 89.74 3.17 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.341 0.591 . . . . 1.46 110.474 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.77 -84.59 1.4 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.337 -0.847 . . . . 0.45 113.994 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -117.19 -3.46 11.5 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.254 0.464 . . . . 1.75 112.254 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -147.4 158.23 43.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.239 0.542 . . . . 2.66 112.402 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -90.81 117.7 29.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.924 -1.034 . . . . 1.85 108.286 171.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 61.8 t -120.74 119.96 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.403 0.62 . . . . 0.45 109.901 -171.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 53.9 m -91.69 122.58 34.37 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.316 -0.856 . . . . 1.1 110.219 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 22.2 t -146.41 164.49 32.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.318 -0.401 . . . . 1.05 110.001 -177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -119.33 79.48 1.42 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 1.56 110.867 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.66 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 8.3 t -76.5 -57.41 3.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.553 0.692 . . . . 1.84 110.823 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' A' ' 5' ' ' CYS . 16.7 p -94.16 29.07 2.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.349 -0.842 . . . . 1.09 112.652 -167.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.324 -0.846 . . . . 1.42 110.622 179.775 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 42.6 p . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.693 0.282 . . . . 2.25 110.755 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.722 ' O ' ' HB2' ' A' ' 19' ' ' SER . 20.7 ttt85 -99.25 24.96 7.33 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.969 0.908 . . . . 3.98 110.184 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.747 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 21.2 mt -32.27 99.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.538 1.31 . . . . 1.15 114.538 -166.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.579 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 39.71 -155.16 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.397 -1.729 . . . . 0.59 113.627 176.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.9 t -102.12 128.47 48.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.834 -0.621 . . . . 1.14 109.503 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.51 -154.82 20.2 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.559 -0.829 . . . . 0.44 111.228 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 38.3 m -115.37 123.74 49.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.551 -0.537 . . . . 1.24 109.551 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.747 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 9.5 p90 -123.4 161.18 25.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.803 -0.635 . . . . 0.41 110.799 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -98.03 114.45 26.6 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.043 0.449 . . . . 0.33 110.405 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -114.35 89.78 3.18 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.839 -0.619 . . . . 1.46 110.546 177.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.18 -87.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.45 114.345 171.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 t -117.01 -9.18 11.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.0 0.4 . . . . 1.75 111.725 -172.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -142.88 159.86 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.085 0.469 . . . . 2.66 110.965 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -89.92 125.89 35.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.555 -0.748 . . . . 1.85 109.022 172.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.483 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 60.9 t -116.49 116.97 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 108.828 -0.804 . . . . 0.45 108.828 -175.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -92.22 130.36 37.95 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.58 -0.737 . . . . 1.1 110.319 178.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -147.06 176.95 9.54 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.905 -1.043 . . . . 1.05 109.416 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.52 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 99.1 mt-30 -132.63 79.83 1.87 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.994 0.425 . . . . 1.56 111.547 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.722 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 7.4 t -81.51 -59.4 2.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.738 0.78 . . . . 1.84 110.069 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.4 m -87.84 32.35 0.74 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.694 -1.139 . . . . 1.09 111.356 -171.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 18' ' ' GLN . 19.5 p . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.225 -0.893 . . . . 1.42 110.049 178.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 121.026 0.441 . . . . 2.25 110.981 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.834 ' O ' ' HB2' ' A' ' 19' ' ' SER . 12.7 tpp180 -112.48 22.43 14.64 Favored 'General case' 0 C--O 1.213 -0.843 0 N-CA-C 109.212 -0.662 . . . . 3.98 109.212 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.696 ' HB ' ' CD2' ' A' ' 8' ' ' TYR . 52.1 mt -33.99 98.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 114.736 1.384 . . . . 1.15 114.736 -163.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER 42.61 -154.15 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.784 -1.553 . . . . 0.59 113.048 175.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.5 m -100.09 137.92 37.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.834 -0.621 . . . . 1.14 110.389 173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 125.02 -152.58 17.67 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 111.384 -0.687 . . . . 0.44 111.384 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 81.6 m -117.51 124.19 48.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.1 0.476 . . . . 1.24 110.01 179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.696 ' CD2' ' HB ' ' A' ' 3' ' ' ILE . 13.4 p90 -124.86 160.57 28.48 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.859 -0.61 . . . . 0.41 110.513 -178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 46.5 t-105 -95.21 111.13 23.01 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.668 -0.413 . . . . 0.33 110.298 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.15 90.54 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.018 -0.537 . . . . 1.46 110.618 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.86 -88.92 1.58 Allowed Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.776 -0.647 . . . . 0.45 114.044 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.9 m -117.24 -6.53 11.3 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.41 0.522 . . . . 1.75 112.41 -173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -147.87 167.32 25.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.416 0.627 . . . . 2.66 112.242 -178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -84.49 124.86 31.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.866 -1.061 . . . . 1.85 108.727 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.441 ' HB ' ' CE1' ' A' ' 8' ' ' TYR . 46.7 t -119.57 113.88 42.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.103 -0.703 . . . . 0.45 109.103 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 4.4 m -93.07 148.33 22.1 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.676 -0.693 . . . . 1.1 111.015 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.7 p -177.56 -178.8 0.77 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.58 -0.736 . . . . 1.05 110.068 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 25.7 mp0 -125.03 79.55 1.8 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.657 -0.247 . . . . 1.56 111.314 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.834 ' HB2' ' O ' ' A' ' 2' ' ' ARG . 6.6 t -71.7 -52.45 17.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.706 0.765 . . . . 1.84 109.741 176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 83.2 m -84.51 12.8 6.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.494 -1.23 . . . . 1.09 111.765 -169.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 18' ' ' GLN . 8.4 p . . . . . 0 C--O 1.244 0.815 0 CA-C-N 116.207 -0.451 . . . . 1.42 110.261 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.494 HG23 HD21 ' A' ' 10' ' ' ASN . 38.6 m . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.565 0.221 . . . . 2.25 110.845 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.585 ' HG2' ' HB3' ' A' ' 19' ' ' SER . 4.4 ttp180 -75.76 32.27 0.11 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.375 0.88 . . . . 3.98 113.375 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.47 ' O ' ' HD2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -59.44 92.27 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.727 0.775 . . . . 1.15 112.129 -176.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.589 ' C ' ' HB2' ' A' ' 19' ' ' SER . 53.7 m 32.06 -167.6 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 115.71 1.744 . . . . 0.59 115.71 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.4 p -102.04 138.34 39.13 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.401 -0.818 . . . . 1.14 111.605 -168.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 16' ' ' CYS . . . 131.96 -143.67 15.26 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.075 -1.21 . . . . 0.44 110.075 -174.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 85.9 m -119.21 123.89 45.42 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 117.197 0.498 . . . . 1.24 110.366 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.47 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 0.3 OUTLIER -128.52 158.13 39.27 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.412 -0.358 . . . . 0.41 110.617 177.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -86.43 99.85 11.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.582 -0.525 . . . . 0.33 109.582 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.494 HD21 HG23 ' A' ' 1' ' ' THR . 54.2 t-20 -91.85 88.48 6.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.201 -0.454 . . . . 1.46 110.066 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.73 -75.17 0.23 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 114.945 0.738 . . . . 0.45 114.945 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.4 t -111.1 -17.1 13.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.858 0.329 . . . . 1.75 111.774 -172.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -148.38 160.16 43.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.239 0.543 . . . . 2.66 112.013 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -83.06 114.63 21.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.176 -0.92 . . . . 1.85 108.923 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.3 t -120.21 117.11 52.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.864 -0.607 . . . . 0.45 109.932 -172.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' GLY . 5.5 m -92.89 146.71 23.42 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.704 -0.68 . . . . 1.1 110.371 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 p -179.33 158.77 0.89 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.482 -0.781 . . . . 1.05 109.998 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 21' ' ' CYS . 48.0 mt-30 -97.16 79.02 2.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.404 0.621 . . . . 1.56 111.281 -176.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.589 ' HB2' ' C ' ' A' ' 4' ' ' CYS . 17.9 m -74.31 -60.92 2.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.529 -0.76 . . . . 1.84 111.262 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 92.2 m -92.69 16.43 12.25 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.976 0.417 . . . . 1.09 110.757 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 18' ' ' GLN . 35.0 m . . . . . 0 C--O 1.244 0.799 0 CA-C-O 118.736 -0.65 . . . . 1.42 109.98 -179.563 . . . . . . . . 1 1 . 1 stop_ save_